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Abstract
Seasonal influenza is associated with signiﬁcant morbidity and mortality among older
adults, aged 65 and older. Since vaccination is the single most effective preventive
measure against seasonal influenza, clinicians and senior citizen center administrators
need a better understanding of the perceptions of older adults concerning the reason for
poor influenza vaccine uptake. The purpose of this study was to identify perceived factors
that may be associated with poor influenza vaccination uptake among older adults. The
health belief model (HBM) guided the study. The research questions examined
perceptions predicting the odds of influenza vaccination uptake among older adults. This
quantitative cross-sectional study consisted of administration of a newly developed 33item questionnaire to a convenience sample of 147 older adult participants. A 2-week
reliability test-retest on 50 participants indicated the instrument had moderate internal
consistency (α ≥ 0.7). Paired-sample t tests were not significant (p > .05), indicating that
participants provided reliable responses across time. Ordinal regression analysis indicated
that all HBM constructs were significantly associated (susceptibility, barriers, benefits,
cues to action, and self-efficacy p = .000; severity p = .002) with frequency of influenza
disease and recency of influenza vaccine uptake within 1 year. The social change
implications from this study may help to improve vaccination uptake among older adults
by providing senior public health decision makers and direct care clinicians with
informed knowledge on perceptions and barriers that may play a role in influenza
vaccination decision-making among older adults.
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Chapter 1: Introduction to the Study
Introduction
Seasonal influenza is a contagious airborne respiratory disease that spreads from
person to person during episodes of coughing or sneezing or through contact with
frequently handled infected surfaces (Centers for Disease Control and Prevention [CDC],
2012-2013). A group of influenza viruses, Types A, B, and C, cause the influenza
disease. These viruses continuously keep changing; every few decades, a new version of
the influenza virus emerges in the human population, causing serious global outbreaks of
disease associated with severe complications, hospitalizations, and death among older
adults (CDC, 2012-2013). The influenza outbreaks can also contribute to social
disruption and economic loss among the population.
This study was conducted because the knowledge gained may help clinicians to
better understand contributing factors associated with decreased influenza vaccine uptake
among the elderly in order to identify strategies that improve influenza vaccine uptake
among older adults. The social change implications in this study are to improve influenza
vaccine uptake among older adults and to provide senior public health decision makers
and direct care clinicians with informed knowledge of the benefits and limitations of
influenza screening and immunization for the older adult population. Other major study
sections included in this chapter are background, problem statement, purpose, research
questions, theoretical framework, nature of the study, definition of terms, assumptions,
scope and limitations, and the significance of the study.
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Background of the Study
A seasonal influenza outbreak usually occurs in the United States in late fall
through early spring, causing severe illnesses and death, especially among the elderly and
children (CDC, 2012). Although influenza affects all ages, older adults are particularly
vulnerable because they often have chronic illnesses, which put them at a greater risk for
influenza complications, including pneumonia (Molinari et al., 2007). Influenza and
pneumonia is the seventh leading cause of death among the elderly (Centers for Medicare
and Medicaid Services (CMS), 2011), and the annual rate of influenza-associated death
among ages 65 and older is 45,321 deaths per 100,000 persons (United States Census
Bureau, 2011).
Individuals with chronic conditions, such as congestive heart failure, asthma, or
diabetes, are particularly at risk for higher incidence, severity, and complications of
influenza attack (CDC, 2013-2014). Although the U.S. government set a national goal of
achieving a 90.0% annual immunization rate for persons over 65 (Healthy People, 2010),
the national rate continues to be at a staggering low for this population (CDC, 2012). The
burden of influenza related illnesses and death from these diseases is greater in Brooklyn
and New York City, which is higher than the nation as a whole (CMS, 2011; SUNY
Downstate Medical Center, 2010). A survey carried out among Brooklyn residents
reported that influenza and pneumonia combined is the third leading cause of death
(CMS, 2011) in Brooklyn (SUNY Downstate Medical Center, 2010). The influenza
vaccine is the most effective in protecting individuals from influenza viruses and related
complications (CDC, 2012). The report from the survey indicated that 46.2% of Brooklyn
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residents over the age of 65 did not receive the annual influenza vaccine compared to
those living in New York City (SUNY Downstate Medical Center, 2010). Three out of
the 11 Brooklyn neighborhoods with a higher percentage of persons 50 to 65 years and
older and never received the influenza vaccine were selected for this study. The three
selected areas with a higher percentage of low influenza vaccine uptakes were Bedford
Stuyvesant-Crown Heights, 62.7%, Canarsie-Flatlands, 72.3%, and East New York,
69.8%. The pneumonia hospitalization rates per 100,000 for people age 65 in the three
selected neighborhoods were Bedford Stuyvesant-Crown Heights, 160.0, CanarsieFlatlands, 100.3, and East New York, 181.4 (Healthcare Association of New York State;
HANYS, and Structured Psychotherapy for Adolescents Responding to Chronic Stress;
SPARCS. 2008). Influenza and pneumonia death rates for these areas in 2000 and 2007
were Bedford Stuyvesant-Crown Heights, 29.0 and 36.6, Canarsie-Flatlands, 21.8 and
16.5, and East New Yok, 30.0 and 31.6 (Equerry: Vital Statistics Mortality Data Sets,
New York City Department of Health and Mental Hygiene; NYCDOHMH, 2009).
There is a gap in knowledge among clinicians in how they handle the influenza
epidemic among older adults. Due to this epidemic, there is an urgent need to evaluate
the perception of the older adults concerning influenza vaccine uptake. Such evaluations
may also help clinicians to identify appropriate strategies in reaching the older adult
population who are at a greater risk for severe complications and death from influenza.
There is an ongoing need for influenza vaccine planning for the older adult population.
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Problem Statement
CDC (2013, 2014) recommended the yearly influenza vaccine as one of the first
and most important steps in protecting individuals against the seasonal influenza viruses.
The seasonal influenza vaccine protects against the three influenza viruses to prevent
unnecessary hospitalizations and premature deaths among older adults (CDC 2012,
2013). Researchers have indicated that many older adults do not obtain the influenza
vaccine despite the many publicized strategies used to promote the importance of
immunization among this age group (Evans, Prout, Prior, Tapper-Jones, Butler, 2007;
Ward & Draper, 2008). Few researchers have focused on identifying the perceptions and
determinants of seasonal influenza vaccination among older adults (Kohlhammer,
Schnoor, Schwartz, Raspe, & Schäfer, 2007; Nagata et al., 2013). Perception about health
plays a critical role in disease consequences (Nagata et al., 2013). Few studies have
addressed the underlying perception of emerging older adults as it relates to the threat of
influenza and the importance of getting the annual influenza vaccine. In addition,
clinician/patient communication is a contributing factor but has not been fully explored
among this age group. In this study, the perceptions of older adults in receiving the
influenza vaccine and clinician/patient communication about the seasonal influenza
vaccine are examined. The key constructs of the health belief model (HBM) and
sociodemographic factors guided the identification of reasons for poor uptake of the
influenza vaccine among older adults in three areas in Brooklyn, New York where the
vaccine uptake is low.
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Purpose of the Study
The purpose of this study was to identify perceived factors that may be associated
with poor influenza vaccination uptake among older adults. Using a quantitative
approach, I intended to identify older adults’ perception about the seasonal influenza
vaccine. Increased uptake of the influenza vaccine can decrease influenza related
complications and death among the older adults.
Nature of the Study
This was a quantitative descriptive study involving cross-sectional data from a
group of respondents 65 years and older in the three selected senior citizen centers in
Brooklyn, New York. The data collected were consistent with understanding the
perceptions of older adults that contributed to poor uptake of the seasonal influenza
vaccination. In addition, data collection identified whether clinician and patient
communication were contributory factors for receiving the influenza vaccination. The
independent variables for this study included the full HBM constructs: perceived
susceptibility, perceived severity, perceived barriers, perceived benefits, perceived cues
to action, perceived self-efficacy, and the mediating demographic factors related to poor
uptake of influenza vaccine among older adults. The dependent variables are recency of
influenza vaccine uptake (≤ 1 year) and frequency of influenza disease (number of
infections within the last year). The covariates consisted of demographic factors such as
gender, age, ethnicity, knowledge, income, employment status, and location and were
used to measure with accuracy those variables that formed the basis for this research.
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The sample included 147 participants. The study sample was selected from three
senior centers that provide both clinical and recreational services. Thus, random sampling
and availability of individual respondents were not feasible as planned. Instead,
participants were selected as a convenience sample consisting of older adult clients who
came into the center and agreed to participate in the study. Participants were interviewed
and recorded until the required sample of 147 respondents was obtained.
Research Questions and Hypotheses
A new HBM scale, Health Belief Model Scale (HBMS) was created based on a
review of past studies that used the HBM. The research questions and the hypotheses
were based on the review of existing literature on seasonal influenza uptake among older
adults and studies that previously used the HBM. To investigate the perceptions of older
adults about the influenza vaccine uptake, the constructs of the HBM and
sociodemographic factors were the focus of the research questions (Glanz, Champion, &
Strecher, 2002). Research Questions 1 through 4 sought to assess participants’
perceptions of severity, risk, susceptibility to the seasonal influenza virus and vaccine,
and vaccine benefits and barriers (Coe, Gatewood, Moczygemba, Goode, & Beckner,
2012; Glanz, Rimer, & Lewis, 2002). Research Questions 5 through 7 sought to assess
mediating factors that include demographic variables (age, gender, ethnicity, and
occupation) associated with the perceptions of the influenza vaccine (Lenzi, Wiens,
Grochocki, & Pontarolo, 2011). Mediator factors also included self-assessment of the
ability to successfully accept the influenza vaccine and external influences such as media
advertisement and flyers; information sorted by older adults or information provided by
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clinicians, family, caregivers, or persuasive communications; and personal experience
that led to the uptake of the influenza vaccine.
Research Question 1. Is there a significant relationship between older adults
perceived susceptibility to the seasonal influenza and frequency and recency of vaccine?
H10: There is no significant relationship between older adults perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
H1A: There is a significant relationship between older adults perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
Research Question 2. Is there a significant relationship between older adults
perceived severity to seasonal influenza based on CDC influenza guidelines?
H20: There is no significant relationship between older adults perceived severity
to seasonal influenza based on CDC influenza guidelines.
H2A: There is a significant relationship between older adults perceived severity to
seasonal influenza based on CDC influenza guidelines.
Research Question 3. Is there a significant relationship between older adults
perceived benefits and the positive consequences of the annual seasonal influenza
vaccine uptake?
H30: There is no significant relationship between older adults perceived benefits
and the positive consequences of the annual seasonal influenza vaccine uptake.
H3A: There is a significant relationship between older adults perceived benefits
and the positive consequences of obtaining the annual seasonal influenza vaccine.
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Research Question 4. Is there a significant relationship between older adults
perceived barriers and discouragement concerning the uptake of the seasonal influenza
vaccine?
H40: There no significant relationship between older adults perceived barriers and
discouragement concerning the uptake of the seasonal influenza vaccine.
H4A: There is a significant relationship between older adults perceived barriers
and discouragement concerning the uptake seasonal influenza vaccine.
Research Question 5. Is there a significant relationship between older adults
perceived cues to action and health care providers’ persuasive communications about
seasonal influenza vaccine?
H50: There is no significant relationship between older adults perceived cues to
action and health care providers’ persuasive communications about seasonal influenza
vaccine.
H5A: There is a significant relationship between older adults perceived cues to
action and health care providers’ persuasive communications about seasonal influenza
vaccine.
Research Question 6. Is there a significant relationship between older adults
perceived self-efficacy and the ability to successfully obtaining the seasonal influenza
vaccine?
H60: There is no significant relationship between older adults perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
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H6A: There is a significant relationship between older adults perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
Research Question 7. Is there a significant relationship between full HBM
constructs plus mediating demographic factors such as age, gender, ethnicity, occupation,
and older adults’ perceptions of the seasonal influenza vaccine?
H70: There is no significant relationship between full HBM constructs plus
mediating demographic factors such as age, gender, ethnicity, occupation, and older
adults’ perceptions of the seasonal influenza vaccine.
H7A: There is a significant relationship between full HBM constructs plus
mediating demographic factors such as such as age, gender, ethnicity, occupation, and the
elderly perceptions of acceptance of the seasonal influenza vaccine.
Research Question 8. Is there significant relationship between influenza vaccine
recency and influenza disease among older adults?
H80: There is no significant relationship between influenza vaccine recency and
influenza disease among older adults.
H8A: There is a significant relationship between influenza vaccine recency and
influenza disease among older adults.
Research Question 9. Is there a significant relationship between influenza disease
frequency and influenza vaccine uptake among older adults?
H90: There is no significant relationship between influenza disease frequency and
influenza vaccine uptake among older adults.
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H9A: There is a significant relationship between influenza disease frequency and
influenza vaccine uptake among older adults.
Theoretical Base
The HBM was developed in the 1950s by Hochbaum, Rosenstock, and Kegels, a
group of public health researchers, in response to a health screening program for
tuberculosis (as cited in Rosenstock, 1966). The model was originally designed to predict
behavioral responses to the treatment received by acutely or chronically ill patients;
however, in recent years, the model has been used to predict general health behaviors
(Ogden, 2007). To accommodate evolving evidence that knowledge and perceptions
played a role in personal responsibility, the model was amended (Glanz, Lewis, & Rimer,
2002). The HBM suggests that the belief in a personal threat together with the belief in
the effectiveness of the proposed behavior will predict the likelihood of that behavior
(Rosenstock, Strecher, & Becker, 1988). The HBM was used in many psychological and
medical studies to help determine an individual’s health thoughts, behaviors, and
wellness (Glanz, Rimer, & Lewis, 2002). Applying the HBM to this study has helped in
providing context of the older adults’ perceptions of the influenza vaccine.
The major theoretical propositions of the HBM are based on core assumptions
that health-related actions are taken when a person believes that a negative health
condition can be avoided. In addition, a positive expectation exists that taking a
recommended action will prevent a negative health condition or that a recommended
health action can be successfully taken comfortably and with confidence (Glanz et al.,
2002). The six constructs of the HBM are perceived susceptibility, perceived severity,
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perceived benefits, perceived barriers, cues to action, and self-efficacy. The four
constructs, perceived susceptibility, perceived severity, perceived benefits, and perceived
barriers, represent the perceived threat and net benefits, which account for a person's
readiness to act. Two constructs that represent the challenges of changing habitual
unhealthy behaviors are cues to action, or activation of readiness and stimulate an overt
behavior, and self-efficacy, which represents a person’s confidence in the ability to
perform an action successfully (Rosenstock et al., 1988). These theoretical propositions
of the HBM supported the hypotheses and are discussed further in Chapter 2.
Operational Definitions
Demographic mediating factors: Refer to modifying variables such as age, sex,
race, ethnicity, and education that may interfere with influenza vaccine uptake indirectly
by affecting perceived susceptibility, benefits, barriers, cues to action, and self-efficacy
(Glanz, Marcus Lewis, & Rimer, 1997; Glanz, Rimer, & Viswanath, 2008).
Frequency of influenza disease: Measurement of the most recent episode of
influenza disease within 1 year or less (CDC, 2013).
Health belief model: The health belief model (HBM) was one of the first health
behavior theories developed in the 1950s by a group of U.S. Public Health Service social
psychologists to explain the reasons why only few people participated in health screening
programs. Since then, the HBM has been widely used in a variety of health behavior
research. The HBM addresses the three distinct areas of perception: perceptions of the
threat posed by a health problem (susceptibility, severity), the benefits of avoiding the
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threat, and factors influencing the decision to act (barriers, cues to action, and selfefficacy; National Cancer Institute; NCI 2005).
Influenza complications: Complications of influenza can include bacterial
pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic
medical conditions, such as congestive heart failure, asthma, or diabetes (CDC 2012 2013).
Influenza disease: Defined as an infectious respiratory disease caused by the
influenza viruses, Types A, B, and C. Types A and B are known as human influenza
viruses that cause seasonal influenza disease almost every winter in the United States.
Influenza virus Type C causes mild respiratory illnesses and is not thought to cause
influenza epidemics (CDC, 2012).
Influenza vaccine: The mandatory vaccine administered to protect against the
three influenza viruses. The various types of influenza vaccines available are the trivalent
inactivated vaccine (TIV) and the live-attenuated influenza vaccine (LAIV). There are
three different influenza vaccines available: a regular influenza vaccine approved for
people ages 6 months and older, a high-dose influenza vaccine approved for people 65
and older, and an intradermal influenza vaccine approved for people 18 to 64 years of age
(CDC 2012-2013; Food and Drug Administration (FDA), 2012).
Influenza virus: The CDC 2013-2014 has reported three types of influenza
viruses: Types A, B, and C. Type A and B are human influenza viruses that cause
seasonal the seasonal influenza disease almost every winter in the United States.
Influenza Type C causes mild respiratory illnesses and is not thought to cause influenza
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epidemics. Influenza A viruses are divided into subtypes based on two proteins on the
surface of the virus: the hemagglutinin (H) and the neuraminidase (N). The current
subtypes of the influenza A virus that have been identified in humans are influenza A
(H1N1) and influenza A (H3N2) viruses (CDC 2009). There is no provision for
describing distinct subtypes of influenza B and C viruses. The existence of antigenic
variation among influenza B strains is well established, but the available information
shows that a division into subtypes is not warranted (World Health Organization (WHO),
1990).
Older adults: For the seasonal influenza immunization administration, the elderly
is described as the group of people aged 65 or older because they are disproportionately
affected by the influenza related complications (Sullivan, Jacobson, & Poland, 2010).
Perceived barriers: An individual’s opinion of what is preventing from making
the decision to adopt a new behavior that can protect and prevent influenza disease
(Glanz et al., 1997).
Perceived benefits: An individual’s beliefs about the safety and effectiveness of
taking the influenza vaccine to reduce risk of getting influenza and the related
complication (Glanz et al., 2002).
Perceived cues to action: A trigger that is necessary for prompting engagement in
the decision-making process to accept a recommended influenza vaccine (Glanz et al.,
1997).
Perceived self-efficacy: An individual's perception of his or her competence to
successfully act in seeking the influenza vaccine (Glanz et al., 1997; Glanz et al., 2008).
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Perceived severity: An individual's beliefs about the seriousness of influenza
disease and how to avoid it (Glanz et al., 1997; NCI, 2005).
Perceived susceptibility: An individual’s beliefs about the chances of getting
influenza disease (Glanz et al., 1997; NCI, 2005).
Recency of influenza vaccine uptake: Measurement of the most recent influenza
vaccine uptake within 1 year or less (CDC, 2013).
Assumptions
The assumptions are necessary in the context of this study because it is presumed
that the study is objective, generalizability is possible, and other studies can be replicated
from this study.
The following are the assumptions of this study:
● Participants have answered the interview questions appropriately by giving a
true and sincere representation of their perceptions of influenza disease and
influenza vaccine.
● Participants have answered the interview questions and provided appropriate
answers that most closely represent their current influenza vaccination status.
● The HBM has been an adequate model to describe the participants’
perceptions of the influenza disease and the influenza vaccine.
● The senior citizen centers have been an adequate setting for the study.
● The research instrument used in this study was adequate and appropriate to
capture the data needed to describe and categorize the participants’ perception
of influenza disease and influenza vaccination.

15

Limitations
In every study, there is a possibility of limitations. Since I used a cross-sectional
design, there is a possibility that there can be a limitation with the strength of the internal
validity. Additional limitations included (a) self-reporting for seasonal influenza
vaccination status, (b) participants’ responses to demographic and instrument questions
only, (c) male and female participants aged 65 and older and who are enrolled in the
selected senior centers in Brooklyn, New York, (d) self-evaluation type of assessment of
the instrument, and (e) voluntary participation from both males and females aged 65 and
older who attended the selected senior centers in Brooklyn, New York. The possible
biases that could influence study outcomes were nonresponses. To minimize this type of
bias, the sample size was large enough to estimate the prevalence of the influenza vaccine
uptake among the older adults in the selected demographic areas of Brooklyn.
Delimitations
The de-limitations of this study are as follows:
1. This study was restricted to seniors who were identified as age 65 or older.
2. This study was restricted to participants recruited through the three senior
centers in Brooklyn.
3. This study was restricted to seniors who read and write English.
4. This study was restricted to seniors free of cognitive impairment and who
could independently make appropriate decisions.
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5. The study was generalized to all three senior centers because the older adults
are of different racial/ethnic backgrounds, which are similar for each of the
representing senior centers.
Significance of the Study
This study contributes to the body of knowledge related to perceptions of older
adults concerning seasonal influenza vaccine uptake. Identifying health care providers’
communication with their patients about the importance of the influenza vaccine safety
and effectiveness can increase the vaccine uptake among this age group. Because older
adults are a high-risk group, such information may be valuable to encourage older adults
to receive the influenza vaccination and therefore significantly reduce the incidence,
complications, cost, and death from influenza and associated conditions. The potential
implications for positive social change bounded by the scope of this study are providing
senior public health decision makers and direct care clinicians with informed knowledge
of the benefits and limitations of influenza screening and immunization of the older adult
population and bringing about improvement in communication between clinicians and
their patients about the importance of the annual seasonal influenza vaccine.
Summary and Transition
Influenza is a common respiratory illness that affects all humans when they are
exposed to the influenza virus. Older adults are particularly vulnerable because they are
in the high-risk category due to their age and existing chronic health conditions (CDC,
2012-2013). According to the CDC (2010), the annual influenza vaccine is the best
method for preventing influenza. However, despite the various methods of
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communication used to raise awareness about the benefits of the influenza immunization,
the immunization rate remains low among older adults. In this study, I examined factors
associated with influenza vaccination among older adults in Brooklyn, New York. The
purpose of the study was to determine what factors contribute to the decision to obtain
the influenza immunizations among older adults.
The HBM was used as the theoretical framework for this study because it
supported the problem, purpose, background, research questions, and research design
decisions, such as the method of inquiry and data collection. Chapter 2 contains a review
of relevant literature pertaining to factors influencing vaccination status among older
adults.
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Chapter 2: Literature Review
Overview
The purpose of this study was to identify perceived factors that may be associated
with poor influenza vaccination uptake among older adults. Despite the availability of the
influenza vaccine, the number of older adults who should be protected from influenza
disease by uptake of the influenza vaccine is far below the national health goals (CDC,
National Center for Health Statistics, 2009). A review of relevant literature indicated that
influenza related complications, hospitalization, and death among older adults is greater
in Brooklyn and New York City, which is due to a decline in uptake of the influenza
vaccine among older adults (SUNY Downstate Medical Center, 2010). Using the HBM, I
sought to understand older adult motivation and decision-making about obtaining the
influenza vaccine.
This literature review, focused on the six constructs of the HBM: perceived
susceptibility to influenza, perceived severity of influenza, perceived benefits of
accepting the influenza vaccine, perceived barriers to obtaining the influenza vaccine,
cues to action (Shahrabani & Benzion, 2012). These constructs relate to the strategies to
activate readiness such as primary caregivers’ communication and reminders about
vaccine importance and availability, providing information to promote awareness. An
additional construct of the HBM is self-efficacy, which focuses on the confidence in the
participant’s ability to take an action in obtaining the influenza vaccine. In addition to
these HBM related constructs, timing of receipt of influenza vaccine (recency) within 1
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year and frequency of influenza disease within the current season are important
determinants of prevention.
The findings in the literature are presented according to the construct of the HBM.
The HBM literature synthesis is preceded with an overview of influenza and its
complications, influenza vaccine guidelines and recommendations, vaccine effectiveness,
side effects, contraindications, recommendations, and economic impact of influenza
disease. A review of current literature was done as well as its application to this study.
The literature review follows and includes studies on influenza vaccine uptake among
older adults both at national and international levels.
Literature Search Strategy
An extensive search was conducted, using key words such as older adults, health
belief model, influenza, influenza complication, influenza vaccine, influenza viruses,
perception, perceived severity, perceived susceptibility, perceived benefits, perceived
barriers, cues to action, self-efficacy, demographic mediating factors, frequency of
influenza disease, and recency of influenza vaccine uptake within 1 year or less. The
scope of literature reviewed included literature from 2007 to 2014; however, since the
HBM is a sentinel model, some of the literature reviewed dates to the 1960s. The types of
literature and sources searched were PubMed: biomedical literature citations and
abstracts, including Medline--articles from medical and peer-reviewed journals including
abstracts, PubMed Central, and other full-text resources that provided free, full text
journal articles. The United States National Library of Medicine (NLM) at the National
Institutes of Health was accessed; Google Scholar, a freely accessible web search engine
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with full text of scholarly literature of various publishing formats and disciplines,
including peer-reviewed online journals, scholarly books, and articles from scholarly
publishers in the United States and other continents of the world.
Theoretical Foundation
The HBM was one of the first social cognition models developed in the 1950s
(Janz & Becker, 1984) to evaluate the uptake of preventive health services and to predict
health behavior change (Rosenstock, 1966). Further development of the HBM was done
to accommodate the evolving evidence that was generated within the healthcare
community about the role knowledge and perceptions played in a person’s personal
responsibility about health (Glanz et al., 2002). In recent years, the HBM was used to
predict more general health behaviors (Ogden, 2007).
The HBM was systematically evaluated by established criteria in evaluating
health behaviors. Since health behaviors are evaluated in this study, the HBM was
considered a better model to explore the hypotheses of this study to show that there is a
relationship among perceived reasons for limited uptake of the influenza vaccine (Glanz,
Marcus Lewis, & Rimer, 1997). The key constructs of the HBM are perceived
susceptibility-- individual's opinion of chances of getting a condition, perceived severity
beliefs about the seriousness of a condition and its consequences, perceived benefits-beliefs about the effectiveness of taking action to reduce risk or seriousness, perceived
barriers--beliefs about the material and psychological costs of taking action to prevent the
disease, cues to action--factors that activate readiness to change the behavior, and selfefficacy--confidence in one’s ability to take action (Glanz, Rimer, & Lewis, 2002). The
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HBM also focuses on other determinants such as demographic variables that include age,
sex, race/ethnicity, income, education, and place of residence as well as personality.
These determinants may indirectly influence how people perceive their risk to diseases
(Becker, Champion 1984; Eisen, Zellman, & McAlister 1992; Glanz et al., 2002; Janz &
Becker 1984, Rosenstock, & Slack 1974; 1985; Walter et al., 1992).
The HBM was used as the theoretical base for this study to explain and predict
health behaviors by focusing on the attitudes and beliefs concerning why older adults do
not obtain the influenza vaccine. In relation to this study, the constructs of the HBM and
the perceived threat of influenza were analyzed, along with the perceived decision to
participate in health-seeking behavior of receiving the influenza vaccine.
The delineation of assumptions appropriate to the application of the HBM for this
study are that people fear disease, and the health actions are motivated by the degree of
their fears and benefits that will bring about behavior change (Becker et al., 1974;
Champion 1984; Eisen et al., 1992; Janz & Becker 1984, 1985; Walter et al., 1992). Each
of the key constructs of the HBM was analyzed in three parts: (a) the individual’s
perceptions of the threat posed by a health problem (susceptibility, severity), (b) the
benefits of avoiding the threat, and (c) factors influencing the decision to act (barriers,
cues to action, and self-efficacy; Janz, & Becker, 1984).
The HBM was selected for this study because it predicts preventive health
behavior by examining belief patterns, and it focuses on the relationship between health
behaviors and the perception of using available health services. It was largely tested
empirically, and its application may help public health and health care professionals to
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develop appropriate strategies to help the older adults in making informed decisions
about the uptake of the influenza vaccine. In addition, the HBM was selected for this
study to examine whether health care professionals’ recommendations about the seasonal
influenza vaccination were significant predictors of patients’ intention to get vaccinated
the vaccine. Figure 1 explains the theoretical preposition of the HBM and provides a way
to understand and predict how an individual may behave in relation to his or her health
and how he or she may comply with preventive health care practices.

Perceptions
regarding influenza
disease, and the
influenza vaccine

Perceived
Susceptibility to
influenza

Modifying
Factors

Perceived Benefit
of the influenza
vaccine
Demographic
Age, Ethnicity,
Income, Education

Cues to Action

Perceived
Severity of
influenza

Perceived
benefit
Perceived
Barriers
to
receiving
influenza
of the influenza
vaccine
vaccine

Likelihood of
Action

Health care providers’
reminders about the
influenza vaccine;
Diagnosis of family or
friends with influence,
Media campaigns

Self-Efficacy
Perceived ability to
overcome perceived
barriers to receiving
influenza vaccine

Projected Related
Anticipated Outcome

Increased uptake of the
seasonal influenza
vaccine
Decreased influenza
related morbidity and
mortality among the
older adults

Figure 1: Uptake of Seasonal Influenza Vaccine among Older Adults based on the new
health belief scale model for influenza vaccine uptake.
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Epidemiology of Seasonal Influenza
The seasonal influenza disease occurs annually in the United States and other
temperate zones during the late fall through early spring (CDC, 2010; World Health
Organization (WHO), 2009). Hospitalizations and deaths occur among the high-risk
population to include the elderly and other high-risk groups (CDC, 2010). The mortality
indicator for all ages exceeded the epidemic threshold because these rates are higher
when compared to the same time last season (CDC 2013-2014).
Worldwide, the influenza epidemic resulted in about 3,000,000 to 5,000,000 cases
of severe illness, and about 250,000 to 500,000 deaths (CDC, 2012; WHO, 2009).
Influenza together with pneumonia is the eighth leading cause of death in the United
States and the fifth leading cause of death among those 65 years old and older
(Kochanek, Xu, Murphy, Miniño, & Kung, 2011) while it is the third leading cause of
death in New York City New York City Department of Health and Mental Hygiene
(NYCDHMH), 2010). Most of these deaths are associated with influenza complications,
which occur among people age 65 or older (CDC, 2012-2013, WHO, 2009). The CDC
(2010) reported that over a period of 31 seasons, between 1976 and 2007, the estimates of
influenza associated deaths in the United States ranged from a low of about 3,000 to a
high of about 49,000 people. Influenza and pneumonia deaths increase with age. More
than 85% of deaths from influenza and pneumonia occurred among people over 65 in
Brooklyn and the rest of New York City (State University of New York (SUNY)
Downstate Medical Center, 2010).
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To estimate the health burden associated with the circulation of influenza viruses,
the CDC uses a 7-component national surveillance system for influenza that includes
virologic, influenza-like illness, hospitalization, and mortality data. These data were used
in statistical models to estimate the possible impact of future pandemics influenza
occurrences. Improving surveillance of influenza helps the CDC and their partners in
different parts of the world including the United States in monitoring the various strains
of influenza that are currently circulating. This type of evidence is needed to detect the
type of circulating viruses, which contribute to appropriateness of the influenza vaccines
that are produced (CDC, 2010).
Every year the occurrences of seasonal influenza place a heavy demand on the
economy and healthcare resources due to the increase in health care consultations,
hospitalizations, clinical complications, and patient treatment that are seen particularly in
the high-risk groups (CDC, 2013). Molinari, et al. (2007) reported that the economic
burden of influenza on the society has been estimated to be $87.1 billion each year,
which includes an average of $10.4 billion in direct medical costs. Unlike countries in the
temperate regions of the world, in some tropical countries, influenza viruses circulate
throughout the year with one or two peaks during rainy seasons (WHO, 2009).
Pathophysiology of Seasonal Influenza, Regulation, and Influenza
Seasonal influenza is an acute contagious respiratory infectious disease caused by
a member of the Orthomyxovirus family, which includes influenza virus A, B, or, to a
much lesser extent, C (CDC, 2013-2014). Several studies reported that the influenza virus
could be transmitted through several distinct mechanisms, such as large droplets from an
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infected person, aerosols, and direct contact with contaminated hosts and surfaces
(Brankston et al. 2007; Tellier 2009; Weber & Stilianakis, 2008). Seasonal influenza
causes mild to severe illness, which causes hospitalization and can lead to death (CDC,
2013-2014; WHO, 2009). Influenza virus is usually replicated in the epithelial cells
throughout the respiratory tract, with the virus being recoverable from both the upper and
lower respiratory tract of people naturally or experimentally infected (Wright, Neumann,
& Kawaoka, 2007). The influenza virus is different from a cold (CDC, 2012). Influenza
symptoms usually occur suddenly once a person is infected with the influenza virus
(CDC 2013). The CDC (2013) reported that some or these symptoms are usually reported
by persons infected with the seasonal influenza virus are fever and chills, cough, sore
throat, runny or stuffy nose, muscle or body aches, headaches, and fatigue. Other
symptoms reported are vomiting and diarrhea, which is more common in children than
adults. Although fever is one of the most common symptoms reported, not everyone with
influenza will have a fever (CDC, 2012-2013, WHO, 2009).
Most people who are infected with the seasonal influenza virus will recover in a
few days to less than 2 weeks, but many will develop complications such as pneumonia,
which can be life threatening and result in death (CDC, 2012-2013; WHO, 2009).
Influenza can occur at any age, but some people are at a higher risk of developing serious
influenza-related complications, including people 65 years and older, people of any age
with certain chronic medical conditions such as asthma, diabetes, or heart disease,
pregnant women, and young children (CDC 2012). The most common complications
reported because of the seasonal influenza are pneumonia, bronchitis, and sinus and ear
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infections. Influenza complications are worst among people with chronic health problems
(CDC 2010; National Center for Biotechnology Information (NCBI), 2009). People with
asthma may experience asthma attacks while those with chronic congestive heart failure
may have worsening of a condition that is triggered by the influenza (CDC, 2013).
However, the most frequent serious influenza complication is pneumonia, which is
categorized into four different types: primary influenza pneumonia, secondary bacterial
pneumonia, pneumonia due to unusual pathogens in immune-compromised hosts, and
exacerbations of chronic pulmonary diseases (CDC, 2013; WHO, 2009). The most
common bacterial pathogens reported are Streptococcus Pneumoniae, Staphylococcus
Aureus, and Haemophilus Influenzae, which act synergistically with the influenza virus
through the increased binding and invasion of bacteria, increased viral replication, and
modification of the host inflammatory response (CDC, 2012; Rothberg, Haessler, &
Brown, 2008).
The severity of the influenza virus can vary widely from one season to another
depending on the circulating influenza viruses, influenza vaccine(s) availability, the
number of people vaccinated, and how well the influenza vaccine matched circulating
influenza viruses (CDC, 2013). Many people die from seasonal influenza each year in the
United States (CDC, 2012). A report in the CDC 2010 provided updated estimates of the
range of influenza-associated deaths that occurred in the United States during the 3
decades prior to 2007. These estimates indicated that influenza-associated deaths ranged
from 3,000 to 49,000 between 1976 and 2007 (CDC, 2010). Death certificate data and
weekly influenza virus surveillance were used to estimate how many flu-related deaths

27

occurred among people whose underlying cause of death was listed as respiratory or
circulatory disease on their death certificate (CDC MMWR 2010, 1057-1062).
The most important method of controlling the seasonal influenza is the annual
influenza vaccination, considered the best method for preventing and controlling seasonal
influenza (CDC, 2012). In addition, the role the annual influenza vaccine plays a key
strategy in assisting the population in preparing for pandemic influenza outbreaks (CDC,
2012). Since influenza is a very infectious disease, older adults, children under the age of
2, and the population with chronic diseases such as diabetes, kidney failure,
cardiopulmonary, and immunocompromised diseases are prone to suffer severely from
influenza (CDC, 2013). In addition, people who are morbidly obese and American
Indians/Alaskan Natives have been classified in recent studies as high risk groups for
influenza complications (Jain, Bairoch, Duvaud, Phan, Redaschi, Suzek, Martin,
McGarvey, Gasteiger, 2009; Morgan et al., 2010). The effects of the serious outcome of
influenza on older adults require that they must receive the influenza vaccine as
recommended by the CDC (2014).
The Health Belief Model
The HBM has been applied in many psychological and medical studies all over the
world with varying success to problems about explaining, predicting, and influencing
behavior (Janz & Becker, 1984). The health belief model to date remains of the most
widely used and well-tested models for explaining and predicting health-related
behaviors (Carpenter, 2010). Since the health belief model has been used in the past to
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predict a wide variety of health-related behaviors such as screening for early detection of
asymptomatic diseases and immunizations uptake it was a suitable fit for this study.
According to Janz, Marshall, Becker (1984) the constructs of the health belief model;
perceived susceptibility, perceived severity, perceived benefits, perceived barriers,
perceived cues to action and perceived self-efficacy are proposed to vary between
individuals and their engagement in health-related behaviors such as getting screened for
asymptomatic diseases and immunization uptake. The model has also been applied to
many studies to understand the participants’ responses to symptoms of disease,
compliance with their medical regimens, and lifestyle behaviors changes in areas such as
sexual risk behaviors and behaviors related to chronic illnesses (Janz, Marshall, Becker,
1984; Glanz, Rimer, Viswanath, 2008).
Rosenstock (1974) and Janz, Marshall, Becker (1984) reported that the health belief
model suggests that the interventions based on the perceived health behavior may aim to
increase perceived susceptibility to a disease and perceived severity of a health condition
by providing education about prevalence and incidence of disease, estimates of risk, and
information about the medical, financial, and social consequences that may change the
health-related behaviors. Perceived benefits of action, perceived barriers to action, and
perceived self-efficacy may predict the engagement or lack of engagement in an healthpromoting behavior while the construct cue to action, must be present to trigger the
required health-promoting behavior (Carpenter, 2010). Other areas that are represented
on the health belief model and need evaluation when using the model are the modifying
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demographic factors outside that may prevent the individual engagement in the desired
health behaviors (Janz, Marshall, Becker, 1984).
A survey conducted in a dwelling community of older adult Greeks who were
having routine access to medical care, identified main reasons and barriers for influenza
vaccine uptake. These included recommendations from health care professionals, beliefs
about the benefits of influenza vaccination, having a relative who delivered the vaccine,
younger than 75 years old, having unpleasant reactions in the past, lack of adequate
information about the side effects of influenza vaccine, and vaccine shortages
(Raftopoulos, 2007).
Banach, Ornstein, Factor, and Soriano (2012) reported that factors associated with
refusal of the influenza vaccine was positively associated with female gender, African
American (Black) race, and living alone; while non-acceptance was negatively associated
with dementia. Studies have reported that after educational sessions about breast selfexamination and clinical examination, practice rates increased (Hajian, Vakilian,
Najabadi, Hosseini, Mirzaei, 2011). Another study reported that those who indicated that
prior vaccination against seasonal influenza reported significantly higher H1N1
vaccination intentions than those who had not been vaccinated (Gidengil, Parker,
Zikmund-Fisher, 2011).
The HBM was successfully used in a study to determine the effectiveness of the
HBM on nutrition education among Type 2 diabetic patients attending Iranian Diabetes
Association seminars and reported knowledge scores increased in the intervention group
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compared to the control group after the intervention was carried out (Sharifirad, Entezari,
Kamran, Azadbakht, 2009).
Influenza Vaccination Uptake Among Older Adults in Brooklyn, New York
New York City Community Health Survey carried out over two-years in
Brooklyn New York was based on the Healthy People 2010 initiative. This initiative set
national goals of achieving a 90 percent rate of immunization against pneumococcal
pneumonia for persons over 65. The survey findings indicated that immunization rates
were far below the national goal for those reported in a national survey. The report from
the survey indicated that 50% of respondents over the age of 65 in New York City and
56% of Brooklyn residents had never been vaccinated (Community Health Survey,
2008).
The factors as indicated that increased the likelihood of being hospitalized with
pneumonia among the older adults were low immunization rates, underlying health
conditions, and poor access to preventive services. Higher hospitalization rates for people
over 65 were observed in several neighborhoods with a greater percentage of older adult
residents. The hospitalization rate when compared by race and ethnicity indicated that
among the over-65 age group, African Americans (Blacks) had a higher hospitalization
rates, followed by Hispanic, European Americans (Whites) residents, Asian and Pacific
Islanders who had lower rates. However, the report indicated Brooklyn had lower rates of
hospitalization for pneumonia than the rest of New York City except for African
Americans (Blacks) Brooklyn residents (2008 Community Health Survey).
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Seasonal Influenza Vaccine Guidelines
The CDC 2010 reported that older adults age 65 years and older are at greater risk of
serious influenza complications compared to young, healthy adults. 90 percent of
seasonal influenza-related deaths and more than 60 percent of seasonal influenza-related
hospitalizations in the United States each year occur among people age 65 years and
older (CDC, 2010). Prevention and immediate treatment of influenza among the older
adults may decrease the risk of influenza-associated complications, hospitalization and
death (CDC, 2012-2013).
Influenza vaccination remains one of the most effective defenses against the
influenza infection and its associated complications (CDC, 2009). The CDC Advisory
Committee on Immunization Practices (ACIP) recommends the use of influenza vaccine
for the prevention and control of influenza (CDC, 2010). High-risk groups recommended
to receive the influenza vaccine are disabled, people in nursing homes, older adults 65
years or older, and individuals with chronic medical conditions. In addition, other groups
such as pregnant women, health care workers, those with essential functions in society, as
well as children from ages six months to two years are also included in this
recommendation (CDC's Advisory Committee on Immunization Practices [ACIP], 2009;
WHO, 2009).
Without preference, the CDC has recommended two types of influenza vaccine
for people 65 and older: a regular trivalent inactivated vaccine (TIV) and the Fluzone
High-Dose vaccine (add citation CDC, 2013). TIV is administered intramuscularly in the
deltoid muscle. Fluzone High-Dose is designed specifically for people age 65 years and
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older. Fluzone High-Dose vaccine contains a higher dose of antigen than regular
influenza shots, and this may give older people a better immune response to the vaccine
(CDC, 2013).
The most common adverse events reported to TIV Vaccine Adverse Event
Reporting System (VAERS) in adults included injection-site reactions, pain, fever,
myalgia, and headache. The TIV VAERS review identified no new safety concerns;
however, the most common serious adverse event reported after receiving TIV VAERS
in adults was Guillain-Barré Syndrome (GBS) (CDC, 2012-2013). According to the CDC
(2012-2013), the potential association between TIV and GBS has been an area of ongoing
research. Injection-site reactions and systemic adverse events among older adults are
most frequently reported after vaccination with the Fluzone High-Dose Sanofi Pasteur
(CDC, 2012-2013). When compared with a standard dose of Fluzone, Sanofi Pasteur
vaccines which contained 45 mcg HA and the Fluzone High-Dose Sanofi Pasteur which
contains 180 mcg of Hemagglutinin HA antigen the side effects of Fluzone High-Dose
Sanofi Pasteur were typically milder and transient (CDC, 2012-2013).
Seasonal Influenza Treatment Guidelines
The CDC 2012-2013 recent report on seasonal influenza hospitalization shows an
increase in hospitalization and death among the older adults. The influenza-associated
hospitalization rate for persons 65 and older was 82 per 100,000, an increase from 69.8
per 100,000 during the prior week. When compared to the same time last season, which
was milder, the influenza-associated hospitalization rate for persons 65 and older remains
within the expected prediction for a moderately severe season (CDC 2012-2013). Among
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laboratory-confirmed influenza hospitalizations, 50% of those hospitalized have been
among persons 65 and older (CDC 2012-2013). Influenza-associated mortality indicators
also increased sharply among all age groups this season with 80 percent of cumulative
deaths had occurred among people 65 years or older.
The CDC has recommended antiviral treatment as an adjunct therapy to reduce
the duration of illness and complications associated with influenza. The antiviral therapy
is recommended for all persons 65 and older with suspected influenza, regardless of the
severity of illness. Treatment of antiviral therapy must be given immediately, preferably
within 48 hours after illness onset. Among hospitalized patients, treatment should be
initiated on admission regardless of onset of symptom. In addition, CDC 2012-2013 has
recommended that the decision to initiate antiviral treatment should be done regardless of
vaccination status and clinicians should not wait on laboratory confirmation of influenza
before initiating antiviral therapy (CDC 2012-2013).
The CDC has recommended the use of Oseltamivir or Zanamivir as the primary
antiviral agents for the prevention and treatment of influenza in the United States during
the 2012-2013 influenza season (CDC, 2012-2013). The CDC reported resistance to
Oseltamivir and Zanamivir among circulating influenza viruses is currently low, but this
finding can change since antiviral resistance can emerge during or after treatment in
patients who are immunosuppressed (CDC, 2013-2014). Both Oseltamivir and Zanamivir
are chemically related antiviral medications known to have activity against both the
influenza A and B viruses. The best clinical outcome occurs when the antiviral therapy is
administered early, within 48 hours of influenza illness onset (CDC, 2013-2014).
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Reported adverse events of Oseltamivir are nausea, vomiting, Sporadic, transient
neuropsychiatric events to include self-injury or delirium which was mainly reported in a
study done among Japanese adolescents and adults (CDC, 2013-2014). Adverse event
that were reported for Zanamivir were diarrhea, nausea, sinusitis, nasal signs and
symptoms, bronchitis, cough, headache, dizziness, and ear, nose and throat infections.
Oropharyngeal or facial edema was reported as an allergic reaction to Zanamivir (CDC,
2013-2014).
The Economic Impact of Influenza
The influenza epidemic continues to pose a serious economic impact on our
society due to increase cost in health care for persons infected with the influenza virus,
loss of productivity and death from influenza complications. Mao, Yang, Qiu, and Yang
(2012) mapped county-level economic impacts of seasonal influenza in the U.S. on four
county-based strategies. They suggested that prioritizing counties with high attack rates
would produce the greatest cost-benefits annual economic impacts of seasonal influenza
since the cost varied from $13.9 thousand to $957.5 million across U.S. counties, with a
median of $2.47 million. Using important contributors such as hospitalization costs, lost
productivity from missed work days and lost lives another study has reported that the
total economic burden of annual influenza epidemics using projected statistical life
values amounted to $87.1 billion (Molinari, Ortega-Sanchez, Messonnier, et al. 2007).
Many studies have focused on the cost-effectiveness of seasonal influenza
vaccination among the older adults age 65 years and older and reported that vaccination
is cost effective if taken by older adults because it decreases doctors’ visits and
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hospitalization (Postma, Baltussen, Palache, Wilschut, 2006). Other published studies
have reported that influenza vaccination is likely to be cost-effective, however the results
of these studies have found to be dependent on some key assumptions used in the
economic evaluations (Newall, Kelly, Harsley, Scuffham, 2009).
Key Constructs
The HBM was applied to this study to predict the perception of the older adults
concerning the influenza vaccine uptake. HBM scale constructs that served as the
independent variables are: perceived susceptibility; perceived severity, perceived barriers,
perceived benefits, and perceived cues to action, perceived self-efficacy, and mediating
demographic factors. The dependent variables are recency of influenza vaccine uptake
and frequency influenza disease within one year or less which represented the efficacy
and effectiveness of influenza vaccination for possible outcome measures, including the
prevention of influenza infection. As a general method of addressing perceived beliefs of
the older adults and the efficacy and effectiveness of influenza vaccination, the literature
review offers a useful structure for understanding a wider range of previous research
findings on belief perception in similar situations.
Perceived Susceptibility to Influenza Disease
Perceived susceptibility is an individual’s beliefs about the chances of getting
influenza (Glanz, Marcus Lewis, & Rimer, 1997; NCI, 2005). In this study, perceived
susceptibility is expressed in two forms those who believe they will benefit if they took
the influenza vaccine because it will protect them from influenza and its complications
and those who believe if they took the influenza vaccine they will get influenza. The aim
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of the clinician is to identify their patients’ ‘belief about the chances of getting influenza
when patients are not yet vaccinated, and tailor information about influenza vaccination
based on their patients’ behaviors. This can help patients to develop an accurate
perception of their own risk if they do not take the influenza vaccine (Glanz, Rimer, &
Lewis, 2002). Researchers have used the HBM to examine the factors associated with
the intention to undergo specific health guidance using health insurance union members
of a company in Japan and reported that perceived threat and net benefit were related to
intention and net benefit had a stronger correlation with intention than did perceived
benefit and barriers (Yamamoto, Mizoshita, and Akamatsu, 2002). Prior influenza
vaccination was associated with higher perceived risk for influenza than unvaccinated;
while those without prior influenza vaccine were unlikely to believe that they would get
influenza (Brewer & Hallman, 2006; Mayo & Cobler, 2004; Nowalk, Zimmerman, Shen,
Jewell & Raymund, 2004; Santibanez et al., 2002; Tabbarah et al., 2005; Telford &
Rogers, 2003; Willis & Wortley, 2007; Zimmerman, Santibanez et al., 2003). Other
studies have shown that individuals who were resistant to influenza vaccination were
concerned about the susceptibility of vulnerable family members, and were willing to get
vaccinated to protect the health of someone they cared about (Bardenheier et al., 2006;
John & Cheney, 2008).
Perceived Severity of Influenza Disease Seriousness
Perceived severity is an individual’s belief about the seriousness of influenza
disease and how to avoid it (Glanz, Marcus Lewis, & Rimer, 1997; NCI, 2005). During
discussion with patients about the importance of influenza vaccination, clinicians must
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specify the consequences of influenza and recommend the influenza vaccine, which is the
most important preventive method available. Studies have reported that perceived
severity is particularly important when susceptibility beliefs are high. Some studies
argued that perceived severity cannot be used by itself as a significant predictor of
influenza vaccination (Armstrong, Berlin, Schwartz, Propert, & Ubel, 2001; Blue &
Valley, 2002; Brewer & Hallman, 2006). Other studies have reported that individuals
whether they were vaccinated or unvaccinated, saw influenza infection as a serious
illness, particularly for persons their own age (Chi & Neuzil, 2004; Lindley, Wortley,
Winston, & Bardenheier, 2006). Ho, Huang, Huang, et al. 2008 examined the risk of
adverse effects of special interest in persons vaccinated against seasonal influenza
compared with unvaccinated persons aged 65 and above. They reported that vaccination
was related to decreased risk for hospitalization.
Perceived Benefit to Influenza Immunization
Perceived benefit is the beliefs about the safety and effectiveness of taking the
influenza vaccine to reduce risk of getting influenza disease and the related complication
(Glanz, Rimer, & Lewis, 2002). The role of the clinician is explaining to their patients the
potential positive results that may occur if they receive the influenza vaccine, how they
can go about getting the vaccine, places where the vaccine is available, and reminding
patients about the appropriate time to take the influenza vaccine (Glanz, Rimer & Lewis,
2002).
One of the most important benefits is the effectiveness of the vaccination why the
vaccine is given every year is to reduce the risk or seriousness of influenza (CDC,
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20010). Several studies have reported that perceived effectiveness of the influenza
vaccine is one of the most consistent predictors of influenza vaccination uptake (Brewer
& Hallman, 2006; Tabbarah et al., 2005). Müller and Szucs (2007) reported the three
most frequent reasons why the elderly accepted the influenza vaccine were: influenza was
a serious illness which people wanted to avoid, having received advice from the primary
care physician or nurse to be vaccinated and not wanting to infect family and friends.
Chiatti, Barbadoro, Lamura, Pennacchietti et al. (2011) surveyed a group of older adults
Italian to examine the determinants of vaccine uptake. Their findings indicated that being
over 85-years old and suffering from a severe chronic disease were the strongest
determinants of vaccine uptake while relying on neighbors' support or on privately paid
home help was also associated with a higher likelihood of vaccine uptake.
Perceived Barriers to Influenza Immunization
Perceived barriers is an individual’s opinion of what is stopping him or her from
making the decision to adopt a new behavior that can protect and prevent influenza
disease (Glanz, Marcus Lewis, & Rimer, 1997). Individuals who oppose the influenza
vaccination are more likely to report experiencing vaccination side effects or getting sick
from the influenza vaccination (Brewer & Hallman, 2006; Chi & Neuzil, 2004; John &
Cheney, 2008; Lindley et al., 2006; Mayo & Cobler, 2004; Tabbarah et al., 2005;
Winston, Wortley & Lees, 2006; Zimmerman, Santibanez et al., 2003). Previous studies
have also documented knowledge barriers (Gosney, 2000; Lindley et al., 2006; Ritvo et
al., 2003), and concern about safety of influenza vaccination are some of the predictors of
poor vaccine uptake (Allison et al., 2010; Chen et al., 2011; John & Cheney, 2008;
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Lindley et al., 2006; Telford & Rogers, 2003; Willis & Wortley, 2007; Wray et al., 2007).
One study reported that despite these findings, about 48% of older adults who had
concerns about the effectiveness of the influenza vaccine and 37% of those who believed
that the influenza vaccine causes illness agreed to vaccinate to protect others
(Bardenheier et al., 2006). Earlier studies have reported that some individuals who were
not vaccinated believed that there were some benefits to vaccination; however, there were
more concerns about costs over the benefits of the vaccine (Bardenheier et al., 2006; Chi
& Neuzil, 2004; Nowalk et al., 2004; Zimmerman, Santibanez, et al., 2003). Clinicians’
role in helping to minimize such barriers is to reassure patients about the vaccine safety
and effectiveness, which can assist in correcting any misinformation. Many barriers to
immunization have been reported. Johnson, Nichol and Lipczynski (2008) reported that
among the most common barriers to immunizations were lack of physician
recommendations and mistaken assumptions while other reasons cited by healthcare
providers were side effects, fear of needles, and lack of insurance coverage as reasons
and practice issues, such as lack of an effective reminder system. Müller and Szucs
(2007) reported that reasons for not accepting the vaccine among older adults who were
never vaccinated included not expecting to contract influenza and not having considered
vaccination as preventive measure.
Cues to Action to Influenza Immunization
Cues to action are a trigger that is necessary for prompting engagement in
decision-making process to accept the recommended influenza vaccine (Glanz, Marcus
Lewis, & Rimer, 1997). The cues to action are strategies to activate readiness which can
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be described as events either bodily symptoms such as a physical symptom of a health
condition or environmental such as media publicity that motivate people to act (Janz and
Becker, 1984). In applying cues to action, health care practitioners’ role is to promote
awareness by providing appropriate information and continuous reminders to patients to
bring about health behavior change (Janz and Becker, 1984). This construct of the HBM
has not received attention in many studies although it plays an important role in health
behavior changes; however, cues to action can be an important practice strategy. Studies
have reported that health care provider recommendations were associated with higher
rates of influenza vaccination uptake (Allison et al., 2010; Chen et al., 2011; Mayo &
Cobler, 2004; Winston et al., 2006) which are primarily one of the contributory factors
for influenza vaccine uptake (Bardenheier et al., 2006; Chi & Neuzil, 2004; Nowalk et
al., 2004; Winston et al., 2006). It has also been reported that to receive the influenza
vaccination, a provider recommendation about the vaccination was more likely to help
with the vaccine uptake (Bardenheier et al., 2006; Chi & Neuzil, 2004; Lindley et al.,
2006; Wray et al., 2007). Some earlier studies have reported that family members’
recommendations were considered another reason for effective vaccine uptake (Nowalk
et al., 2004; Zimmerman, Nowalk, et al., 2003; Zimmerman, Santibanez, et al., 2003).
Earlier studies have also reported that these recommendations were effective in the
influenza vaccine uptake (Mayo & Cobler, 2004). Physician and other clinicians’
recommendation and reminder systems for the influenza vaccine are associated with
increases in vaccination rates significantly (Anderson, Goeree, Sebaldt, Donald, Lohfeld,
et al., 2008). Such practice strategies can be cost-effective in preventing the
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complications of influenza. Studies have reported that that many physicians and other
healthcare providers do not routinely recommend influenza vaccines to their adult
patients, despite evidence showing that the clear majority of patients will receive
vaccinations if their health-care provider recommends them (Johnson, Nichol, &
Lipczynski, 2008; Schwartz, Neale, Northrup, Monsur et al., 2006).
Self-Efficacy to Influenza Immunization
Self-efficacy is the confidence and the ability to make successful informed
decisions Glanz, Rimer & Lewis, 2002). Fewer studies related to influenza vaccination
examined the role of self-efficacy, perhaps because vaccination is a simple, time-limited
behavior that does not require lifestyle adjustments or changes to complex health
behaviors such as adhering to an exercise program or eating a healthier diet (Brewer &
Rimer, 2008; Champion & Skinner, 2008). Earlier studies have reported that in the case
of influenza vaccination, self-efficacy does not appear to be an important determinant of
influenza vaccination among adults (Chapman & Coups, 1999). Clinicians can
incorporate the construct of self-efficacy in helping their patients to build their
confidence by providing training, guidance and positive reinforcement about the
influenza vaccine (Glanz, Rimer & Lewis, 2002). Such confidence can be evaluated by
discussion with patients about their experience with prior influenza vaccine, which may
build confidence, decrease doubts, and help to eliminate barriers. Clinicians can also
incorporate discussion in the form of a brief anonymous survey after a skill building
session to elicit questions or concerns that may remain on the patient’s mind (Glanz,
Rimer & Lewis, 2002).
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Patient education and recommendation for the influenza vaccination by clinicians
can address any doubts and misinformation patients may have. Zimmerman et al. (2003)
reported that patient education and recommendation for the influenza vaccination by
healthcare providers can help to increase the likelihood of patients receiving the vaccines
by eliminating misconceptions, vaccine-related concerns and myths. Research have found
that healthcare providers can increase vaccination rates among the older adults by
critically addressing patients’ concerns about the possible side effects and interaction
with other medication they may be taking to manage chronic illnesses (Wray, Jupka,
Ross et al., 2007; Wray, Jupka, Ross et al., 2009).
Demographic Mediating Factors to Influenza Immunization
Demographic mediating factors refer to modifying variables such as age, sex,
race, ethnicity, and education that may interfere influenza vaccine uptake indirectly by
affecting perceived susceptibility, benefits, barriers, cues to action and self-efficacy
(Glanz, Marcus Lewis, & Rimer, 1997; Glanz, Rimer, Viswanath (2008). Influenza is a
preventable health problem affecting the older adults that can lead to serious medical
complications (CDC, 2014). Many individuals do not embrace the health benefits
associated with influenza vaccination and they continue to doubt the vaccine the vaccine
safety which can contribute to the hesitancy of vaccine uptake (Yaqub et al., 2014). For
people to make changes in their health beliefs about the influenza vaccine, they must
believe that the changes will benefit their health and that they can make such changes
(Zimmerman, et al., 2003). By counseling older adult patients and acknowledging their
fear and susceptibility to influenza can help them to make changes in their behavior,
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which will motivate them to make informed decisions (Johnson, Nichol, Lipczynski,
2008). Older adults are already aware that increased age and history of chronic diseases
place them at increased risk for influenza and the related complications. There are also
those who are not aware of their risk and there will be an increase need for health
behavior change among this group. Individuals with different methods of learning might
be influenced by different cues, such as television influenza vaccine commercials, flyers
and posters with influenza vaccine messages, influenza vaccine campaign, advice from
family and friends, education and reminders from healthcare providers, and their own
personal reasons, such as a loved one who suffered with influenza or have already taken
the influenza vaccine. Dexter, Teare, Dexter, Siriwarden, Read, (2012) reported that the
independent factors associated with performance that predicted higher vaccination rate
for at-risk patients which included clear leadership, effective communication about
performance and methods used to identify and contact eligible patients were
independently associated with significantly higher rates of flu vaccination. Banach,
Ornstein, Factor, Soriano, 2012 reported that the association between social, demographic
and health-related characteristics and influenza vaccine refusal among people ages 65 and
over were positively associated with female gender, African American (Black) race, and
living alone. Chiatti, Barbadoro, Lamura, Pennacchietti, et al 2011 surveyed a group of
Italian to determine influenza vaccine uptake and reported that being unmarried and
living in larger households were risk factors for lower immunization rates among elderly
Italians.
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Recency of Influenza Vaccine Uptake
Recency refers to measurement of the most recent influenza vaccine uptake
within one year or less (CDC, 2013). Influenza vaccine is required every year for two
reasons: (1) the body’s immune response from vaccination declines over one year, so an
annual vaccine is needed for optimal protection; and (2) the influenza viruses are
constantly changing causing the formulation of the influenza vaccine to reviewed and
updated each year based on the circulating viruses (CDC, 2011). Every year the influenza
disease places many at risk older adults for influenza complications and hospitalizations
(CDC, 2013). Studies have shown that recency of influenza vaccine uptake within one
year or less has proven to be safe and effective in preventing influenza and its
complication among the (CDC, older adults 2010). Studies have reported that there is an
age-related decline in immune responses in the older adults causing a greater
susceptibility to infection and reduced responses to vaccination (Skowronski, Tweed &
Serres, 2008). Other studies have indicated that a low protective effect of the influenza
vaccine suggest a decline in vaccine effectiveness in the older adults over time post
vaccination therefore annual influenza immunization of high-risk populations against
influenza remains the most important preventive method (Castilla, Martinez-Baz,
Martinez-Artola et al., 2013)
According the CDC (2013), antibodies against the influenza viruses begin to
appear one to two weeks after receiving the influenza vaccine and last for several months,
and sometimes even up to one year. Since the immune response to the influenza vaccine
declines in a year or less and the influenza virus is constantly changing, the CDC (2013)
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recommended that for optimal protection, the annual influenza vaccine is needed each
year. Songa et al. (2010) compared long-term immunogenicity of influenza vaccine
among older and younger adults during an interval period of 1, 6, and 12 months after
vaccination. The findings indicated that neuroprotection rates at 1-month postvaccination ranged from 70.1% to 90.3% depending on the age group and influenza
vaccine virus strain; at 6-months post-vaccination, seroprotection rates for all three
strains had declined significantly in older adults (p <0.01). Low pre-vaccination HI titer
(<1:40) and advanced age were associated with early decline of HI titers, falling below
seroprotective levels around 6 months after vaccination (Songa et al., 2010)
Frequency of Influenza Disease
Frequency of Influenza disease refers to measurement of the most recent episode
of influenza disease within one year or less (CDC, 2013). Influenza vaccine is one of the
most recommended method of reducing influenza complication, hospitalization and death
among the older adults CDC, 2013). The uptake of influenza vaccine uptake within a year
or less can decrease the frequency of influenza disease among the older adults (CDC,
2010). According to the CDC (2013), the efficacy of the influenza vaccine is measured
by comparing the frequency of influenza illness among persons vaccinated and those who
have not been vaccinated with the influenza vaccine. Studies have indicated that those
who had received the influenza vaccine in a year or less had a decrease incidence in
influenza and its complication. Although immune response to the influenza vaccine
declines in a year or less the vaccine is still effective in preventing complications and
death among older adults (CDC, 2013). It has been reported that the influenza vaccine is

46

50%–60% effective in preventing hospitalization and 80% effective in preventing death
(CDC, 2012). A survey carried out in Genesee County, Michigan during the influenza
outbreak from 1982–1983 to evaluate unvaccinated nursing home residents. Findings
from this survey indicated that unvaccinated older adult residents were four times more
likely to die than were vaccinated older adults’ residents (CDC, 2010).
Literature Providing Differing Views
The effectiveness of the influenza vaccine is a concern that is debatable among
many researchers. Although the influenza vaccination provides some protection and may
prevent complications due to pneumonia, hospitalizations, and death, the effectiveness is
variable. Reports from a recent systematic review and meta-analysis of influenza vaccine
protection identified that there was 59% effectiveness of the trivalent influenza vaccine in
adults aged 18 to 65 years and a higher effectiveness (83%) of the live-attenuated vaccine
(LAIV) in children (Osterholm, Kelley, Sommer, & Belongia, 2012). Another study
reported that influenza vaccination was associated with a 27% reduction in the risk of
hospitalization for pneumonia or influenza and a 48% reduction in the risk of death
(Nichol, Nordin, Nelson, Mullooly & Hak, 2007). Simonsen et al. (2009) argued that
although placebo-controlled randomized trials show influenza vaccine is effective in
younger adults; few trials have included older adults, and especially those who are at
least 70 years, which accounts for three-quarters of all influenza-related deaths.
Literature on Methodology
Many the literature reviewed were both qualitative and quantitative in nature and
they investigated personal characteristics which were thought to be predictors of
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influenza vaccine uptake, such as age, sex, comorbidity, educational level, income and
specific area of residence (Dexter, Teare, Dexter, Siriwarden, Read, 2012). Several
studies used telephone survey to identify predictors of and barriers to vaccine uptake
(Böhmer et al., 2012; Banach, Ornstein, Factor, & Soriano, 2012; Johnson, Nichol, &
Lipczynski, 2008). Many quantitative studies used the Likert scales, open ended and
closed ended questions, and self- report for vaccination status to measure constructs for
factors (Johnson et al., 2008; Santibanez et al., 2010). Coe, Gatewood et al. (2012) used
anonymous, self-administered questionnaire based upon the HBM to assess participants’
perceptions of severity, risk, and susceptibility to the novel H1N1 influenza virus and/or
vaccine. Other predictors identified were prior experience, concerns about the vaccine,
perceived risk and advice and information from clinicians and caregivers (Johnson,
Nichol, Lipczynski, 2008; Schwartz, Neale, Northrup, Monsur et al. 2006). However,
since the main goal of this research is to use the HBM to identify the individuals’
perception of the influenza vaccine, studies that focused on the health beliefs, attitudes,
perceptions and subjective experiences of older adults were most beneficial to this study
(Chiatti, Barbadoro, Lamura, Pennacchietti, et al 2011; Müller, and Szucs, 2007;
Raftopoulos, 2007; Gidengil, Parker, Zikmund-Fisher, 2011; Banach, Ornstein, Factor,
Soriano, 2012).
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Summary and Transition
The literature reviews for this study introduced the background of the study,
problem statement, its effect on the older adults, influenza virus and its complications
among the elderly. The research review demonstrated the importance of
recommendations and guidelines for influenza control among the older adults, guidelines
and recommendation for management of influenza among the older adults, barriers that
have been identified to explain why the older adults may not receive the seasonal
influenza vaccine. Some inconsistencies in the recommendations for influenza
management among the older adults were identified, the specific perceptions regarding
diagnosing and treating seasonal influenza has only been briefly explained. This study
contributes to gaps in the literature by addressing older adults’ perceptions, beliefs and
adherence to influenza vaccine recommendations and the importance of clinician/
communication about the seasonal influenza vaccine. Most clinicians are in the position
to have a major influence on their patients since they have developed a trusting
relationship. Establishing better communication and reminders may assist in increasing
influenza vaccine uptake by the older adults. With the increasing healthcare costs related
to influenza epidemic and its complications among the older adults, and the increasing
number of older adults in our society warrant there is an urgent need for this research.
The HBM is used in this study as a theoretical guide for predicting influenza vaccine
uptake among the older adults and therefore guides this research methodology. The
rationale for this study was developed to identify significance of the perception of
participants involved and explain how the research plans were carried out. The study’s
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conceptual background and methodology were defined based on the constructs of the
HBM. The design for this study was chosen based on existing literature about influenza
vaccine uptake among older adults.
Chapter 3 begins with a brief discussion of the steps used in the literature review.
It describes in detail the: study design, sample, setting, data collection procedures, and
data analysis. Protection of human participants and limitations of the study are also
addressed.
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Chapter 3: Research Method
Introduction
The purpose of this study was to identify perceived factors that may be associated
with poor influenza vaccination uptake among older adults. In this quantitative study, I
developed a new scale to measure the HBM constructs associated with influenza vaccine.
In this chapter, the study design, sample, setting, data collection procedures, and data
analysis are discussed. Protection of human participants and limitations of the study are
also addressed.
Research Design and Approach
This was a descriptive study using a quantitative cross-sectional design where
self-administered questionnaires were used. In this study, I identified the correlation
between patients’ perception of the severity of the influenza epidemic and the importance
of the influenza vaccine uptake. Based on the nature of this study, a cross-sectional
approach was appropriate because the intention of this study was to determine whether
there is a relationship between older adults’ perceptions of influenza epidemic and the
importance of the annual uptake of the influenza vaccine.
In this study, I explored older adult perceptions of the influenza epidemic and
how these perceptions guide the likelihood of obtaining of the seasonal influenza vaccine
as well as the effects of contribution of providers’ communication in helping to raise the
awareness about the influenza vaccine. The questionnaire was designed to provide a
quantitative display of the participants’ perception that guides their behaviors in
obtaining the seasonal influenza vaccine.
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The independent variables are the HBM constructs: perceived susceptibility,
perceived severity, perceived barriers, perceived benefits, perceived cues to action,
perceived self- efficacy, and mediating demographic characteristics including gender,
age, educational level, annual income, and place of residence. The dependent variables
were recency of influenza vaccine uptake and frequency of influenza disease within 1
year or less, which represented the efficacy and effectiveness of influenza vaccination for
possible outcome measures, including the prevention of influenza infection.
Setting and Sample
The purpose of this section is to discuss the setting, the sample selection, sample
size calculation and rationale, and eligibility criteria. The study took place in three senior
citizens center in the suburban areas of Brooklyn, New York. The area is populated with
approximately 40% African Americans, 20% Hispanics, 10% Asians, and 30% European
American (Whites).
The sample consisted of 147 participants from three senior citizen centers
suburban area of Brooklyn, New York. A convenience sample was used since random
sampling and availability of individual respondents may not be feasible. Older adult
clients who were members of the selected senior centers and agreed to participate in the
study were selected until the required sample of 147 respondents was obtained. Inclusion
criteria consisted of (a) men and women, (b) ages 65 years and older, (c) English
speaking, (d) oriented to person, time, and place, (e) members of the selected senior
citizen centers, and (f) able to understand the English language. I prescreened the
participants who responded to the request to participate in the study for eligibility prior to
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data collection. Prescreening consisted of explaining to each participant about the nature
of the study and by signing the consent form that they were agreeing to participate in the
study. Participants were asked again if they still wished to continue in the study; once
they agreed to participate in the study, they were interviewed. I then set up the participant
to begin completing the questionnaires/surveys.
Justification for Choice of Methodology
A quantitative cross-sectional study design was used to measure the factors and
provide descriptive statistical findings on a selected population of elderly who attended
three senior centers in Brooklyn, New York. Another reason for selecting this design was
to better explain the hypotheses and determine the correlation between the independent
and dependent variables. According to Creswell (2009), quantitative strategies quantify
relationships between variables and emphasize mathematical measurement, using
statistical analysis. The survey approach used a 33-item group administered questionnaire
where participants answered the questions using a 5-point Likert scale (1-Strongly
Disagree to 5-Strongly Agree) and provided answers to open ended and closed ended
questions concerning their perception of influenza vaccine uptake.
Instrumentation and Materials
Development of a New Survey
The review of the literature did not identify surveys measuring perceptions of
older adults concerning using the HBM, but it was important for me to identify the
perceptions of older adults based on the HBM. The closest instrument prototype was
Champion's Health Belief Scales for Mammography Screening, 1997. The newly created

53

survey instrument was developed using information from the literature on previous
research studies that have used the HBM. The questions were initially created after
reviewing other studies that investigated many topics using the HBM, concerning the
perception of older adults’ perception about vaccine uptake. The HBM was used to
evaluate older adults’ perception of influenza disease and vaccine uptake questions that
were categorized based on the six constructs of the HBM: perceived susceptibility,
perceived benefit, and perceived seriousness, perceived barriers, cues to action, and selfefficacy, and demographic mediating factors. Recency of influenza vaccine uptake and
frequency of influenza infection within 1 year or less were included in the instrument
questionnaire. The survey instrument consisted of a 33-item questionnaire. A total of 25
questions were based upon the constructs of the HBM, six questions were based on
demographic mediating factors, one question was based on the frequency of influenza
disease, and one question was based on recency of influenza vaccine uptake. Questions 1
through 4 were developed to assess the subject's perceived severity to seasonal influenza.
Questions 5 through 7 were developed to assess perceived susceptibility of seasonal
influenza. Questions 8 through 14 addressed perceived clinical barriers to seasonal
influenza vaccination. Questions 15 through 17 addressed perceived benefits of the
influenza vaccine. Questions 18 to 21 addressed cues to action concerning a reminder
from clinicians and family members as well as information from posters, books, or
television. Question 22 through 25 addressed perceived self-efficacy concerning
confidence in obtaining the seasonal influenza vaccine. Five questions concerning
demographics mediating factors, age, gender, race/ethnicity, and estimated annual

54

income, were also used in the survey. Also, two questions concerning recency of
influenza vaccine uptake and frequency of influenza disease were assessed. Each section
of the questionnaire used a 5-point Likert scaled response set (1--strongly disagree, 2–
disagree, 3--neither agree nor disagree, 4–agree, 5--strongly agree) except for frequency
of the influenza disease that was measured using 0 to 4 or more times, and recency of
influenza vaccine uptake was measured using never to most recent. The survey did not
contain any identifiable patient information.
Validity and Reliability
Since this was a newly constructed scale, there were concerns about the
methodological issues of validity and reliability of the scale. To address the
methodological issues of validity and reliability of the scale, an expert review panel was
asked to assess and revise the survey prior to official data collection. To improve the
instrument validity, all feedback from the expert panel concerning the instrument was
discussed among the group and corrections were made.
The reliability of the instrument was determined by measuring internal
consistency (Cronbach’s alpha) and a test-retest reliability (correlation coefficient). Testretest reliability was tested by administering identical versions of the scale items at two
different occasions under the same conditions after 2 weeks. The degrees of similarity
between the two test-retest reliability measurements were determined by computing a
correlation coefficient. For the reliability analysis, 50 older adult volunteer participants
were asked to retake the survey 2 weeks after the first administration.
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Expert Panel Review Process
The expert panel who reviewed the survey questionnaire for validity and
reliability were selected using the criteria based on education, profession, and experience
with research. Three medical doctors and three nurse practitioners were selected to
participate in the expert panel review. The expert panel provided timely feedback, and the
survey was revised based on the consensus of the group. An overview of the purpose of
the study and the constructs of the HBM and mediating factors were presented to group
members to ensure that all members were familiar with the aim of the instrument's
development. The group was asked to evaluate the survey questions for face validity.
Group members were given a copy of a draft questionnaire. The Expert Review Panel
form (Appendix D) was provided to each member to review with a section for their
written editorial comments. Changes to the survey were based on the expert panel
suggestions, and they were asked to review the revised survey (Appendix D). The
timeframe for this process was 30 days. The Expert Review Panel members were
instructed to be candid and provide comments that truly reflected how they felt. A journal
was kept to record individual member input. The instrument was refined during each
meeting until a consensus was reached on the content of the instrument and the validity
of the items.
Final Survey Instrument
The finalized survey instrument included 33 structured questions (Appendix D).
A total of 25 questions were based upon the constructs of the HBM and demographic
mediating factors. Four questions assessed perceived severity to seasonal influenza.

56

Three questions assessed perceived susceptibility of seasonal influenza. Seven questions
addressed perceived clinical barriers to seasonal influenza vaccination. Three questions
addressed perceived benefits of the influenza vaccine. Four questions addressed cues to
action concerning reminders from clinicians and family members and information from
posters, books, or television. Four questions addressed perceived self-efficacy concerning
confidence in obtaining the seasonal influenza vaccine. Five questions concerning
demographics mediating factors such as age, gender, race/ethnicity, and estimated annual
income, was used for the survey. In addition, two questions concerning recency of
influenza vaccine uptake and frequency of influenza disease were assessed. Each section
of the questionnaire used a 5-point Likert scaled response (1--strongly disagree, 2–
disagree, 3--neither agree nor disagree, 4–agree, 5--strongly agree) except for frequency
of the influenza disease that was measured using 0 to 4 or more times and recency of
influenza vaccine uptake that was measured using never to most recent. The survey did
not contain any identifiable patient information.
HBM Constructs and Survey Items
Perceived susceptibility was based on the participants’ subjective perception of
the risk of acquiring influenza and the variation of the person's feelings of personal
vulnerability to influenza infection. Perceived severity assessed the participants’ feelings
on the seriousness of contracting the influenza infection and whether if left untreated,
there is a possibility of related complications. The extent to which feelings about
influenza severity may affect a person to consider the medical consequences varies, such
as hospitalization from complications or death, and social impact on family life and other
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social relationships. Perceived benefits assessed the participants’ perception of the
effectiveness of the influenza vaccine to reduce the threat of influenza infection. The
course of action the participant would take to prevent influenza infection disease was in
consideration and evaluation of both perceived susceptibility and perceived benefit, such
that the person would accept the recommended health action if it was beneficial.
Perceived barriers assessed participants’ perceived beliefs about the obstacles to the
uptake of the influenza vaccine. There is wide variation in perceived barriers that leads to
a cost/benefit analysis; therefore, the person may weigh the effectiveness of the influenza
vaccine against the perceptions that it may be expensive or dangerous because of side
effects, causes unpleasantness such as pain, be time-consuming, or be inconvenient. Cue
to action assessed the stimulus needed to trigger the decision-making process to accept a
recommended influenza vaccine. These cues can be advice from healthcare practitioners,
illness of a family member, a newspaper article, and television commercials. Selfefficacy assessed the level of participants’ confidence in their ability to successfully
receive the influenza vaccine. Demographics mediating factors were age, gender,
race/ethnicity, estimated annual income, and place of residence. The dependent variables
were the frequency of influenza disease within 1 year or less and recency of influenza
vaccine uptake within 1 year or less.
Analytical Process of Correlating Variables
Each research question was answered by testing the corresponding hypotheses.
The variables used for hypothesis testing included the independent variables, which were
the perceptions of older adults’ beliefs about the influenza disease and influenza vaccine
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uptake as a preventive method, and the dependent variables, which were the frequency of
influenza disease within 1 year or less and recency of influenza vaccine uptake within 1
year or less.
Scoring of Independent and Dependent Variables
Independent variable perceived susceptibility was scored 1 to 5 on a subscale of
four items with an ordinal range of 4 to 20. Independent variable perceived severity was
scored 1 to 5 by a subscale of three items with an ordinal range of 3 to 15. Independent
variable perceived barrier was scored 1 to 5 by a subscale of six items with an ordinal
range of 3 to 15. Independent variable perceived benefit was scored 1 to 5 by a subscale
of three items with an ordinal range of 3 to 15. Independent variable perceived cues to
action was scored 1 to 5 by a subscale of four items with an ordinal range of 4 to 20.
Independent variable perceived self-efficacy was scored 1 to 5 by a scale of four items
with an ordinal range of 4 to 20. The six mediating demographic variables are presented
in Table 1, including gender, age, race, educational attainment, income, and place of
residence.
The dependent variables for this study are frequency of influenza disease and
recency of influenza vaccine. The measures of frequency of influenza disease and
recency of influenza vaccine consisted of derived binomial distribution (1 = infection ≤ 1
year; 0 = everyone else). The responses to the questions were indicated as numerical
values with increasing numbers indicating increased agreement regarding the variable.
Tables 1, 2, and 3 illustrate the type of variables, description of the level of agreement
each survey questions, type of statistical analysis, and values of the response categories.
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Table 1
Independent Variables for Hypotheses Testing
Variable

Description

Type

Values

Perceived
Susceptibility

Likelihood of getting
influenza disease

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

Impacted if they were
affected by influenza
disease

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

The benefits and effective
the influenza vaccine

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

Logistic Regression
Odds Ratios and 95%
Confidence Intervals

1=Strongly Disagree
2=Disagree
3=Neither Agree nor
Disagree
4=Agree
5=Strongly Agree

Perceived
Severity

Perceived
Benefits

Perceived
Barriers

The difficulties encounter in
taking the obtaining the
influenza vaccine

Cues to
Action

The prompts that are needed
to move the person into the
state where they are ready
to take the influenza
vaccine.

Self-Efficacy

The confidence and belief in
their own ability to take the
influenza vaccine
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Table 2
Dependent Variables for Hypotheses Testing
Variable

Description

Type

Values

Frequency

Number of times had
influenza in past year

Logistic Regression
Binomial distribution
1=# infections ≤ 1
year;
0=everyone else

0=0 times
1=1 time
2=2 times
3=3 times
4=4 or more times

Recency

Last time the influenza
vaccine was received

Logistic Regression
Binomial distribution;
1=within the year;
0=everyone else

1=Never
2=> 3 years
3=2-3 years ago
4=Last year
5=This year
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Table 3
Demographic Variables for Descriptive Analysis and Hypotheses Testing
Variable

Type

Values

Gender

Nominal

1=Male
2=Female

Age

Ordinal

1=65-69
2=70-74
3=75 or greater

Race/Ethnicity

Nominal

1=European Americans (Whites)
2=African American (Black)
3=Hispanic
4=Asians
5=Other, specify: _________

Education

Ordinal

1=Grade School
2=Some High School
3=High School Diploma/GED
4=Some College
5=Bachelor Degree
5=Graduate/Professional Degree

Place or residence

Nominal

1=Family house
2=Own house alone
3=Residence for senior citizens
4=Other, specify

Income

Ordinal

1=Under $10,000
2=$10,000 - $19,999
3=$20,000 - $29,999
4=$30,000 - $39,999
5=$40,000 - $49,999
6=$50,000 - $59,999
7=$60,000 or above.
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Protection of Human Participants
Walden IRB Approval
Each senior center was contacted and approvals by the directors were acquired
before carrying out the survey. The data collection began after IRB approval was
obtained on February 3, 2015 (IRB # 02-04-15-0145747). The participants in the study
were older adults, aged 65 and older and fall under the vulnerable category of human
participant protection requiring a full board review and approval. The IRB at Walden
determined the appropriate human rights protection of the participants. Maintaining
confidentiality and privacy of participants and securing informed consent were important
to maintain the integrity of this study. Each participant received a consent form at the
beginning of the survey describing the study and explaining that participation was
voluntary. Those participants who voluntarily agreed to participate in the survey
proceeded with the consent. Participants only used initials of first and last names on the
authorization form before screening was done. All research data will be stored for 5 years
and will be destroyed after such time.
Screening for Dementia
The prevalence of dementia increases from less than 1% among people 65 years
of age or younger, to an estimated 3–11% among those 65-84 years old, and to around
33% of those aged 85 years and older (Boutsani, et al., 2003; Lobo, et al. 2000; Rocca, et
al. 1990; Skoog, et al. 1993). Studies have also reported that cognitive impairment, not
dementia (CIND), is even more common, with an estimated prevalence of around 17% in
people 65 years and older (Graham, Rockwood, Beattie, et al. 2003). To maintain the
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integrity of this study the General Practitioner Assessment of Cognition (GPCOG)
(Brodaty et al., 2002) was used as a brief four to five minutes screening test for cognitive
impairment of all participants who voluntarily agreed to participate in the study. Prior to
the GPCOG-screening participants signed an authorization form. The participants’
GPCOG screening evaluation contained the following cognitive test items: time
orientation, clock drawing, reporting a recent event and a word recall task. A GPCOGparticipant score of 9 indicates no cognitive impairment and was used as an inclusive
criterion for the study. If a GPCOG-participant score is between 5 and 8, the GPCOGinformant interview was administered but these participants were not included in the
study. During the informant interview the informant was asked about the older adults’
memory of recent conversations, misplacing objects, word finding difficulties, ability to
manage money, ability to manage medication, and need for travel assistance. A GPCOGparticipant score of 4 or lower or a GPCOG-informant section score of 3 or lower
suggests cognitive impairment (Brodaty et al., 2002). Each older adult participant who
received the cognitive screening score of nine or more and voluntary agreed to participate
in the study received a consent form and consent explanation sheet that described the
study and explained that participation or the completion of the survey was voluntary.
Anonymity
Participant anonymity was achieved through using initials of first and last names
in the consent form. The raw data were managed only by me and no participant contact
information was available about this survey. Before proceeding with the survey each
participant was informed that they have the right to stop the survey at any time if they
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had any doubts. Since this research was not an invasive procedure there was no
foreseeable harm to the participants in this study. Although the participants may not have
personally benefited from this study, the study may provide valuable information for
improvement in influenza vaccine uptake among the older adults.
Test-Retest Participation
All participants of the test-retest component of the study were asked to volunteer
to take the survey two times, at the initial meeting and again two weeks later. If
participants agreed, they checked “yes” on the question and enter their e-mail address.
The e-mail was used to contact those participants two weeks later. The purpose of the
GPCOG and the reason for doing the screening were explained to all participants who
volunteered to participate in the GPCOG.
Data Collection
The survey was conducted at each of the three sites using the same method until a
sample of 147 participants was obtained. Data was collected from May through July,
2015. The survey took about 30 to 45 minutes to complete. I introduced myself to the
prospective participant who volunteered to participate in the study and explained the
purpose of the survey, how the survey would be distributed, the steps participants would
take to complete the survey, the screening and consent processes, privacy and
confidentially, the research variables, and data management. Participants were asked to
answer survey questions in the same order as the items were printed. Extra care was taken
during the data collection phase to ensure completeness of self-report and prevention of
the occurrence of missing data. Before surveys were collected, the questionnaire was
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examined for completeness and accuracy, and participants were asked to complete any
missing questions.
Statistical Analyses
Data were entered directly into Microsoft Excel using keystrokes. Each entry was
rechecked to prevent and identify data entry errors. Data were imported from Excel to
SPSS (Statistical Product and Service Solutions) version 21. Range and frequency checks
were used to ensure that none of the variables were outside the range of possible values.
Data collected from the survey were tabulated for analysis using SPSS to identify
frequencies, and correlation coefficients. The data related to each hypothesis are
presented separately and analyzed as follows:
Research Question 1. Is there a significant relationship between older adults
‘perceived susceptibility to the seasonal influenza and frequency and recency of vaccine?
H10: There is no significant relationship between older adults perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
H1A: There is a significant relationship between older adults perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
Statistical Plan: Independent Variable = Perceived susceptibility; Dependent
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine.
Statistical analysis was ordinal logistic regression used on multiple independent variables
to predict influenza disease, recency of influenza vaccine uptake, and frequency of
influenza disease based on older adults’ perceived susceptibility. Null hypothesis was
rejected if p <.05.
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Research Question 2. Is there a significant relationship between older adults
perceived severity to seasonal influenza based on CDC influenza guidelines?
H20: There is no significant relationship between older adults perceived severity
to seasonal influenza based on CDC influenza guidelines.
H2A: There is a significant relationship between older adults perceived severity
to seasonal influenza based on CDC influenza guidelines.
Statistical Plan: Independent Variable = Perceived severity; Dependent Variables
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical
analysis was ordinal logistic regression analysis used on multiple independent variables
to predict influenza disease, influenza vaccine uptake, frequency and recency of influenza
vaccine based on older adults’ perceived severity. Null hypothesis was rejected if p <.05.
Research Question 3. Is there a significant relationship between older adults’
perceived benefits and the positive consequences of the annual seasonal influenza
vaccine uptake?
H30: There is no significant relationship between older adults’ perceived benefits
and the positive consequences of the annual seasonal influenza vaccine uptake.
H3A: There is a significant relationship between older adults’ perceived benefits
and the positive consequences of obtaining the annual seasonal influenza vaccine.
Statistical Plan: Independent Variable = Perceived benefits; Dependent Variables
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical
analysis was ordinal logistic regression analysis used on multiple independent variables

67

to predict influenza disease, influenza vaccine uptake, and recency of influenza vaccine
based on older adults’ perceived benefits. Null hypothesis was rejected if p <.05.
Research Question 4. Is there a significant relationship between older adults’
perceived barriers and discouragement concerning the uptake of the seasonal influenza
vaccine?
H40: There no significant relationship between older adults perceived barriers and
discouragement concerning the uptake of the seasonal influenza vaccine.
H4A: There is a significant relationship between older adults’ perceived barriers
and discouragement concerning the uptake seasonal influenza vaccine.
Statistical Plan: Independent Variable = Perceived barriers; Dependent Variables
= Frequency of influenza vaccine uptake and recency of influenza vaccine. Statistical
analysis was ordinal logistic regression analysis used on multiple independent variables
to predict influenza disease, influenza vaccine uptake, and recency of influenza vaccine
based on older adults’ perceived barriers. Null hypothesis was rejected if p <.05.
Research Question 5. Is there a significant relationship between older adults’
perceived cues to action and health care providers’ persuasive communications about
seasonal influenza vaccine?
H50: There is no significant relationship between older adults’ perceived cues to
action and health care providers’ persuasive communications about seasonal influenza
vaccine.
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H5A: There is a significant relationship between older adults’ perceived cues to
action and health care providers’ persuasive communications about seasonal influenza
vaccine.
Statistical Plan: Independent Variable = Perceived cues to action; Dependent
Variables = Frequency of influenza vaccine uptake and recency of influenza vaccine.
Statistical analysis was ordinal logistic regression analysis used on multiple independent
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza
vaccine based on older adults perceived cues to action. Null hypothesis was rejected if p
<.05.
Research Question 6. Is there a significant relationship between older adults’
perceived self-efficacy and the ability to successfully obtaining the seasonal influenza
vaccine?
H60: There is no significant relationship between older adults’ perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
H6A: There is a significant relationship between older adults’ perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
Statistical Plan: Independent Variable = Perceived self-efficacy; Dependent
Variables = Frequency of influenza vaccine uptake and recency of influenza vaccine.
Statistical analysis was ordinal logistic regression analysis used on multiple independent
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza
vaccine based on older adults’ perceived self-efficacy. Null hypothesis was rejected if p
<.05.
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Research Question 7. Is there a significant relationship between full HBM
constructs plus mediating demographic factors such as age, gender, ethnicity, occupation,
and older adults’ perceptions of the seasonal influenza vaccine?
H70: There is no significant relationship between full HBM constructs plus
mediating demographic factors such as age, gender, ethnicity, occupation, and older
adults’ perceptions of the seasonal influenza vaccine.
H7A: There is a significant relationship between full HBM constructs plus
mediating demographic factors such as such as age, gender, ethnicity, occupation, and the
elderly perceptions of acceptance of the seasonal influenza vaccine.
Statistical Plan: Independent Variable = HBM constructs and mediating
demographic factors; Dependent Variables = Frequency of influenza vaccine uptake and
recency of influenza vaccine. Statistical analysis was ordinal logistic regression analysis
used on multiple independent variables to predict influenza disease, influenza vaccine
uptake, and recency of influenza vaccine based on older adults’ perceptions and
demographic factors. Null hypothesis was rejected if p <.05.
Research Question 8. Is there significant relationship between influenza vaccine
recency and influenza disease among older adults?
H80: There is no significant relationship between influenza vaccine recency and
influenza disease among older adults.
H8A: There is a significant relationship between influenza vaccine recency and
influenza disease among older adults.
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Statistical Plan: Independent Variable = Perceived susceptibility; Dependent
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine.
Statistical analysis was ordinal logistic regression analysis used on multiple independent
variables to predict influenza disease, influenza vaccine uptake, and recency of influenza
vaccine based on older adults’ perceived susceptibility. Null hypothesis was rejected if p
<.05.
Research Question 9. Is there a significant relationship between influenza
disease frequency and influenza vaccine uptake among older adults?
H90: There is no significant relationship between influenza disease frequency and
influenza vaccine uptake among older adults.
H9A: There is a significant relationship between influenza disease frequency and
influenza vaccine uptake among older adults.
Statistical Plan: Independent Variable = Perceived susceptibility; Dependent
Variables = Frequency of influenza vaccine uptake and Recency of influenza vaccine.
Statistical analysis was ordinal logistic regression analysis used on multiple independent
variables to predict influenza disease frequency, influenza vaccine uptake, and recency of
influenza vaccine based on older adults’ perceived susceptibility. Null hypothesis was
rejected if p <.05.
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Threats to Validity
Threats to External Validity
The study was carried out at three senior centers in Brooklyn, New York and
these locations may not be representative of all older adults. The sample was purposive
and nonprobabilistic. The study sought to test a newly developed instrument and provide
information about influenza uptake among Brooklyn seniors. Since age played a major
factor causing the effect of the influenza vaccine to vary from one individual to the other,
then age differences between the sampled older adult participants and the general
population would lead to a biased estimate of the average influenza vaccine effect in that
population. In this study, such bias was corrected by a simple re-weighing procedure: The
age-specific effect in the older adult subpopulation was computed using the average age
distribution in the general population which gave an unbiased estimate of the average
influenza vaccine treatment effect in the general population.
Threats to Internal Validity
Some elderly might misinterpret the instructions on how to complete the survey.
The direction on how to complete the survey was read twice to each older adult and each
older adult could ask for help or ask questions while completing the survey before
proceeding to answer the survey questions. Completing the survey questionnaire took 30
to 45 minutes and the survey was administered in the mornings before other activities to
prevent shift in focus due to tiredness or fatigue. Participants were allowed extra time if
they requested to complete answering the questions.
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Dissemination of Findings
The growing rate of influenza and its complications among older adults is a public
health concern (CDC, 2013). Recent reports from the CDC, 2013-2014 indicate that the
influenza hospitalization rates among persons 65 and older increased greatly while 80
percent of cumulative influenza-associated deaths occurred among this age group. There
is a direct request for better influenza surveillance to assist in controlling the impact of
influenza and to identify vaccine improvement, which is important for influenza
complication prevention among older adults (PAHO, WHO, 2013).
The goal of health care professionals and policy makers is to reduce the rate of
influenza among the older adults. The study results were shared with the New York State
Department of Health and local health departments in Brooklyn, NY. The results of the
study will be submitted for publication in peer-reviewed journals such as American
Journal of Public Health and other nursing journals. In addition, the outcome of the study
can contribute to the gap in literature about the importance of annual uptake of influenza
vaccine as the main method of prevention of influenza disease and its complication
among the older adults.
Summary and Transition
The study design, sample, setting, data collection procedures, and data analyses
were discussed in this chapter. Protection of human participants and limitations of the
study were also addressed in this chapter. A quantitative cross-sectional design was used
to identify the prevalence of seasonal influenza vaccine uptake among the older adults.
The study made use of a convenience sample of older adults who attended the three
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selected senior centers in Brooklyn, NY. Data were collected using a 33-item
questionnaire based on the HMB concepts, demographic mediating factors, frequency of
influenza disease, and recency of influenza uptake.
The questionnaire consisted of items related to the six constructs of the HBM plus
mediating demographic factors to identify the perception of the elderly concerning the
seasonal influenza vaccine. In addition, frequency of influenza disease and recency of
influenza vaccine uptake were evaluated. Understanding factors that influence influenza
uptake among older adults, awareness can increase among primary care providers and
other clinicians regarding the importance of routine influenza vaccine reminders and
recommendations. Chapter 4 provides the results of the survey and statistical analysis of
the final interview.
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Chapter 4: Results
Introduction
The purpose of this study was to identify perceived factors that may be associated
with poor influenza vaccination uptake among older adults. The HBM guided this study.
This quantitative study was used to answer nine research questions to evaluate older adult
perceptions of annual seasonal influenza vaccine and factors that may contribute to poor
influenza vaccine uptake. A new instrument was developed, and test-retest reliability was
analyzed among a small sample of older adult participants. A survey approach was used
for the data collection. In this chapter, factor analysis to measure the newly created HBM
constructs is described. Descriptive analysis illustrates the demographic characteristics of
the sample participants. The examination of correlations of older adult perceived health
beliefs, recency of influenza vaccine, and frequency of influenza disease are reviewed. In
addition, logistic regression analyses performed to test the hypotheses are discussed
between HBM model predictors of frequency and recency of influenza disease within the
last years.
Characteristics of Participants
Participants who spoke and read English were recruited from the three senior
centers using a convenience sample approach. Data were collected from May through
July 2016. The survey took about 30 to 45 minutes to complete. The total number of
participants who consented to the survey was 162, of which 15 were excluded from the
analysis because they did not meet the research criteria due to cognitive impairment as
evidenced by the inability to think clearly, concentrate, and recall new information. The
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findings presented reflect a final sample of 147. Table 4 shows the demographic
distribution of the participants, by gender, age, and race, highest level of education,
annual income, and place of residence. Most the sample were female (74%) and between
the ages of 65 to 70 (77%). Most the participants identified themselves as members of
minority groups, including 40% African Americans, 28% Hispanics, 6% Asians, and
26% European Americans. About a third of the sample had at least some college
education, and 45% had a household income under $10,000. Most of the participants in
the sample lived independently either alone in their own home (38.4%) or in senior
citizen housing (33%).
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Table 4
Frequency of Demographic Characteristics of Participants (n=147)
Variable
Gender
Male
Female
Age
65 -70
70- 75
75 or greater

Frequency

Percent

38
109

25.8
74.2

113
31
3

76.9
21.1
2.0

Race
European Americans
African Americans
Hispanic
Asians

38
59
31
9

Highest Education
Grade School
Some High School
High School Diploma/GED
Some College
Bachelor Degree and higher

18
29
24
16
30

12.1
19.7
16.3
10.9
20.4

Annual Income
Under $10,000
$10,000 - $19,999
$20,000 - $29,999

66
59
22

44.9
40.1
15.0

Type of Residence
Family house
Own house alone
Residence for senior citizens’ home

43
55
49

29.3
38.4
33.3

25.9
40.1
27.9
6.1
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Pilot Test Results
Reliability Test Retest Analysis
The survey was administered twice to 50 older adult participants who volunteered
to retake the survey 2 weeks after their initial survey. According to Trochim (2008), the
test-retest reliability is used to assess the consistency of a measure at two different time
periods. Paired-samples t tests were run on the different construct items susceptibility,
seriousness, barriers, benefits, cues to action, and self-efficacy (see Tables 5, 6, 7, 8, 9,
and 10). The comparison of the mean perceptions across the two-time periods (perceived
seriousness, susceptibility, barriers, benefits, and cues to action) resulted in a probability
greater than 0.05, indicating that there were no significant differences between the
administration times. The lack of differences in the two test administration times
indicated that the instrument was reliable and was adequate for the survey.
Perceived Susceptibility
The construct of perceived susceptibility is an individual’s perception about the
chances of getting the influenza disease, a serious disease, which may later lead to the
motivation to adopt the appropriate health behavior to decrease the risk of getting
influenza. I tested the susceptibility construct with three items, using a 5-point Likert
scale with response categories being strongly disagree to strongly agree and scored 1 to
5, with 0 for missing answers. A factor analysis was computed with the three perceived
susceptibility items that indicated that there were no significant differences between the
two test administration times. Table 5 shows the paired-samples t test of test-retest
reliability of perceived susceptibility.
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Table 5
Paired Samples t-test for Test-Retest Reliability of Perceived Susceptibility
Scale items
If I get the
seasonal
influenza virus
I will get sick.
If I get the
seasonal
influenza virus
I will lose
income.
If I get the
seasonal
influenza virus
other members
in my home
will get sick.
If I get the
seasonal
influenza virus
I will die

Test 1
mean(SD)

Test 2
mean(SD)

Correlations

Mean
differences

p

t

4.82(.440)

4.70(.610)

.472

.094

.292

1.076

4.89(.349)

4.84(.444)

.387

.119

.099

1.705

4.30(1.016)

4.04 (1.00)

.156

.229

.258

1.156

4.78(.439)

4.68(.610)

.460

.092

.293

1.074

Perceived Severity
The construct of perceived severity refers to the participants’ perception about the
seriousness of influenza disease and its prevention. The perceived threat of influenza
disease among older adults is a serious health concern. I tested the 4-item perceived
seriousness construct, using a 5-point Likert scale with response categories ranging from
strongly disagree to strongly agree and scored 1 to 5, with “0“ for missing answers.
Although some mean differences are negative as indicated, the correlations and p values
showed reliability. Therefore, correlation between the test and retest administration times
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were reliable. Table 6 shows the paired-samples t test of test-retest reliability between
perceived seriousness and influenza vaccine
Table 6
Paired Samples t-test for Test-Retest Reliability of Perceived Severity
Scales

Test 1
mean(SD)
4.08(.930)

Test 2
mean(SD)
4.06(.716)

My family
members are
at risk for
getting the
seasonal
influenza
virus.

4.27(.643)

I feel
knowledgeabl
e about my
risk of getting
the seasonal
influenza
virus.

4.88(.392)

I am at risk for
getting the
seasonal
influenza virus

p

t

Correlations
.773

Mean
differences
-.026

.804

-.256

4.44(.546)

.445

-.207

.040

-2.150

4.79(.425)

.046

.086

.184

.185

Perceived Benefit
The construct of perceived benefit refers to participants’ perception about the
safety and effectiveness of taking the influenza vaccine to reduce the risk of getting
influenza disease and the related complications. I tested three perceived benefit items
using a 5-point Likert scale with response categories being strongly disagree to strongly
agree and scored 1 to 5, with 0 representing missing answers. This subscale was reliable
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because as indicated there were no significant differences between the times of
administration of the two tests. Table 7 displays the results of the paired-sample t test for
each item in the benefit subscale, which shows the correlations and p values reliability.
Table 7
Paired-Samples t-test of Test-Retest Reliability of Perceived Benefits
Scale items

Test 1
mean(SD)

ρ

Mean
differences

p

t

2.79(1.220)

.396

-.333

.095

-1.711

2.88(1.064)

2.57(.914)

.623

.310

.026

2.308

2.45(.999)

2.40(.862)

.542

.049

.738

.340

If I receive the
seasonal
influenza
2.45(1.064)
vaccine, I will
not get sick
from the
seasonal
influenza virus
If I receive the
seasonal
influenza
vaccine it will
prevent
complications
from the
seasonal
influenza
disease
Seasonal
influenza
vaccines are
safe.

Test 2
mean(SD)
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Perceived Barriers
The construct of perceived barriers refers to participants’ opinion of what is
stopping them from making the decision to get the influenza vaccine that can protect and
prevent influenza disease. I tested the barriers construct with seven items using a 5-point
Likert scale with response categories being strongly disagree to strongly agree and
scored 1 to 5, with 0 representing missing answers. This subscale was reliable, as there
were no significant differences between the two test administration times. Table 8
displays the results of the paired-sample t test for each item in this benefit subscale. As
noted below, some mean differences are negative, but the correlations and p values show
reliability.
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Table 8
Paired-Samples t-test of Test-Retest Reliability of Perceived Barriers
Scale items
I will have side
effects from the
seasonal
influenza
vaccine.
I will get sick
from the
seasonal
influenza
vaccine.
I will die from
the seasonal
influenza
vaccine.
The seasonal
influenza
vaccine will be
painful.
The seasonal
influenza
vaccine will be
expensive.
It is
inconvenient to
get the seasonal
influenza
Vaccine
There is a
shortage of the
seasonal
influenza
vaccine

Test 1
mean(SD)
4.89(.349)

Test 2
mean(SD)
4.80(.408)

Mean
differences
.068

p
.184

T
1.356

2.89(1.168) 2.89(1.111) .693

024

.864

.173

2.55(.987)

2.68(1.162) .444

-.070

.691

-.401

4.10(.749)

4.00(.946)

.639

.049

.675

.423

2.01(.782)

2.06(.924)

.620

.000

1.000

1.80(.850)

1.88(.762)

.787

.070

1.000

.001

1.89(.931)

1.95(.740)

.493

.000

.600

.536

ρ
.617
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Perceived Cues to Action
Cues to action are the factors that trigger that are necessary for prompting
engagement in the decision-making process to accept the recommended influenza
vaccine. I tested the cues to action construct using a five point Likert scale with response
categories being strongly disagree to strongly agree and scored 1-5 with 0 representing
missing answers This subscale was reliable, as there were no significant differences.
Table 9 below shows the paired-samples t-test of test-retest reliability of perceived cues
to action about influenza vaccine.
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Table 9
Paired-Samples t-test of Test-Retest Reliability of Perceived Cues to Action
Scale items
I will take the
seasonal
influenza
vaccine if my
doctor or my
nurse said it is
important
I will take the
seasonal
influenza
vaccine if a
family member
or significant
other said it is
important
I will take the
seasonal
influenza
vaccine if I see a
TV ad that said
it is important
I will take the
seasonal
influenza
vaccine if the
interdisciplinary
team at my
clinic reminds
me.

Test 1
mean(SD)

Test 2
mean(SD)

1.95(.812)

1.98(.723)

2.65(1.160)

p

t

.197

-.048

.757

-.315

.506

.049

.798

.264

2.16(1.034)

-.120

.398

-.870

.643

.359

.262

.674

2.60(1.204)

2.04(.812)

4.18(1.059)

ρ

Mean
differences

4.30(.865)

Perceived Self-Efficacy
The perceived self-efficacy construct measures the participants’ perception and
the competence to successfully take an action in seeking the influenza vaccine. In this
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case the elderly who received information about the influenza vaccine from close friends
and relative, the media or health care providers were motivated to receive the influenza
vaccine. This increased the knowledge and confidence to obtain the influenza vaccine. I
tested the four perceived self-efficacy subscales using a five point Likert scale with
response categories being strongly disagree to strongly agree and scored 1-5 with 0
representing missing answers. The correlation between the two test administration times
shows reliability. Table 10 below shows the paired-samples t-test of test-retest reliability
of perceived self-efficacy about influenza vaccine uptake.
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Table 10
Paired-Samples t-test of Test-Retest Reliability of Perceived Self-Efficacy
Scale items
I am confident
that I can obtain
the seasonal
influenza vaccine

Test 1
mean(SD)
3.72(.935)

Test 2
mean(SD)
3.90(.901)

ρ
.550

Mean
differences
-.199

p
.165

t
-1.434

I am confident
3.70(.793)
that my day to
day performance
will not be
adversely
impacted by
taking the
seasonal influenza
vaccine

3.58(1.001) .485

.124

.406

.844

I am confident
that the seasonal
influenza vaccine
I will take will
not exposed me to
any side effects or
death

4.22(.858)

.615

-.144

.268

-1.190

3.29(1.200) .178

-.170

.480

-.726

4.10(.980)

I am confident
3.20(1.135)
that seasonal
influenza vaccine
will help to
prevent me from
getting the
seasonal influenza
throughout the
influenza season.

To estimate test-retest reliability, I administered the same test to the same group
of 50 elderly participants on two different occasions. The amount of time allowed
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between measures was two weeks. Based on the results of the two tests the value of the
correlation was considered satisfactory. The results therefore demonstrated that the items
in the instrument have good test-retest reliability and moderate to good construct validity
for all items.
Factor Analysis
An Exploratory Factor Analysis (EFA) was done using SPSS to measure the
reliability of the constructs that reflected the perceived behavior of older adults related to
influenza vaccine uptake (IBM, SPSS). The process used for conducting the EFA
involved three stages: Extraction, Rotation and Interpretation (IBM, SPSS). During the
extraction process I looked at the process of determining how many factors within the
data set best explained the observed covariation matrix. The appropriate number of
factors to extract was determined by Eigenvalues and Scree plot. Since I was interested in
explaining as much variance in observed indicators with the fewest latent factors, I
decided to retain only those latent factors with sufficiently high eigenvalues. All the
factors that were retained had an eigenvalues value above 1.
The other alternative method used was inspecting the scree plot to determine the
appropriate number of factors to retain and to correctly consider the relative size of the
eigenvalues rather than the absolute size. Rotation was done to maximize the factor
loadings for the items that best measure their respective factor. The interpretation of the
data was done by naming the factors to provide a meaningful understanding of the
common feature among the relevant items.
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Cronbach’s alpha was calculated to measure internal consistency to see how
closely the set of items were related as a group. In addition to measuring internal
consistency, Cronbach’s alpha was used to test items and the average inter-correlation
among the items to provide evidence that the scale is appropriate. Table 10 below shows
the Cronbach’s alpha coefficients. Since Cronbach’s alpha reliability coefficient normally
range between 0 and 1, with 0.7 being acceptable, all constructs were retained.
Table 10
Cronbach’s Alpha Coefficients of Health Belief Model Subscales
Health belief model
Subscales
Susceptibility

Cronbach’s alpha
coefficients based on
standardized items
.810

Severity

.710

Benefits

.875

Barriers

.729

Cues to action

.802

Self-efficacy

.836

Source: Newly developed influenza vaccine uptake scale
Assumptions
It is assumed that the nonparametric tests measured the relationship between
variables and the residuals are normally and independently distributed. Assumptions can
be made that descriptive statistics appropriately characterized the sample. Assumptions
were made prior to data analysis that the data were screened for linearity,
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homoscedasticity, normality, and multicollinearity. It was assumed that based on the
analyses result there was lack of collinearity among the independent variables.
Assumptions were made during the planning phase of the study to generalize the sample
and the sample was representative of the population of older adults who attended the
three senior centers in Brooklyn, New York. Assumptions associated with factor analysis
showed that the data were analyzed using descriptive statistics, factor analysis, ordinal
regression and correlation coefficient. It can also be assumed that data was assessed for
missing values and adequate sample size. The test retest paired-sample t-tests reliability
assumes that consistency of assessment of the test remained stable across time.
Assumptions indicated that each independent variable can be assigned to the dependent
variables. In addition, it was assumed that ordinal logistic regression was adequate to
analyze the hypotheses predictor variables. It was assumed that the dependent and
independent variables had ordinal levels of measurement. Since the independent variables
did not highly correlate to each other, it can be assumed that the ordinal logistic
regression analyses were adequate and correct.
Research Questions and Hypotheses
Nine specific research questions were addressed in this study. The results of the
statistical analyses are presented in this section. The ordinal logistic regression analyses
were performed to test the best set of predictor variables based on constructs of the HBM
to identify the outcomes of older adult influenza vaccine uptake frequency and recency.
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My intention for this first research question was to determine if there was a
significant relationship between older adult perceived susceptibility to seasonal influenza
and frequency and recency of vaccine uptake.
1. Is there a significant relationship between older adults ‘perceived susceptibility to the
seasonal influenza and frequency and recency of vaccine?
H10: There is no significant relationship between older adults’ perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
This hypothesis was not supported.
H1A: There is a significant relationship between older adults’ perceived
susceptibility to the seasonal influenza and frequency and recency of vaccine.
This hypothesis was supported based on the following results.
There were four specific items combined in the perceived seriousness construct.
Ordinal logistic regression statistics were run between this construct, cue to act, and selfefficacy and the two dependent variables recency of influenza vaccine. The model fit for
the null hypothesis can be rejected as the observed significance for the severity construct
and self-efficacy construct resulted in a p = .002 and the severity construct and cues to
action resulted in a p =.000.
The parallel lines for seriousness were tested using the predictor variables
susceptibility, cues to action and self-efficacy. The null hypothesis of parallelism for risk
and cues to action, (p = 1.000, -2 log likelihood 168.984) do not have sufficient evidence
to reject the null hypothesis indicating that ordinal regression using the log-log function
is appropriate for these data. The null hypothesis of parallelism for risk and self-efficacy,
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(p = .480, -2 log likelihood 160.588) do not have sufficient evidence to reject showing
that ordinal regression using the log-log function is appropriate for these data.
2. Is there a significant relationship between older adults perceived severity to seasonal
influenza based on CDC influenza guidelines?
H20: There is no significant relationship between older adults perceived severity
to seasonal influenza based on CDC influenza guidelines. This hypothesis was not
supported based on the following results
H2A: There is a significant relationship between older adults perceived severity to
seasonal influenza based on CDC influenza guidelines. This hypothesis was
supported based on the following results
Examination of the data suggests that there are significant associations between
the severity construct questions and the dependent variables. There were five specific
items combined in the severity construct. Ordinal regression statistics were run between
this construct, predictor variables, cues to action and self-efficacy and the two dependent
variables. The model fit null hypothesis can be rejected as the severity construct and selfefficacy construct is a determining factor which resulted in a high degree of significance
(p = .000) and the susceptibility construct and cues to action were significant as well (p =
.000).
The parallel lines for severity question in this section were tested using the
predictor variables severity, cues to action and self-efficacy. The null hypothesis of
parallelism for seriousness and cues to action, (p = 1.000, -2 log likelihood 158.896) do
not have sufficient evidence to reject showing that ordinal regression using the log-log
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function is appropriate for these data. The null hypothesis of parallelism for severity and
self-efficacy, (p = .450, -2 log likelihood 128.782) do not have sufficient evidence.
My intention for research question three was to determine if there was a significant
relationship between older adult participants’ perception of benefits and the positive
consequences of annual seasonal influenza vaccine uptake.
3. Is there a significant relationship between older adults’ perceived benefits and the
positive consequences of the annual seasonal influenza vaccine uptake?
H30: There is no significant relationship between older adults’ perceived benefits
and the positive consequences of the annual seasonal influenza vaccine uptake.
This hypothesis was not supported and was rejected.
H3A: There is a significant relationship between older adults’ perceived benefits
and the positive consequences of obtaining the annual seasonal influenza vaccine.
This hypothesis was supported based on the following results.
Examination of the data suggests that there is a significant relationship between
the perceived benefits construct and the dependent variable recency of influenza vaccine
uptake. The items combined in the perceived benefits construct and ordinal regression
statistics were run between perceived cue to act and self-efficacy construct and the
dependent variable recency of influenza vaccine. The model fit null hypothesis can be
rejected as the observed significance for the barriers construct and self-efficacy construct
resulted in a p = .000 and the barriers construct and cue to act resulted in a p = .000.
The parallel lines for benefit question in this section were tested using the
predictor variables, barriers, cues to action and self-efficacy. The null hypothesis of
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parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 250.360) do not
have sufficient evidence to reject showing that ordinal regression using the log-log
function is appropriate for these data. The null hypothesis of parallelism for barriers and
self-efficacy, (p = 1.000, -2 log likelihood 272.515) do not have sufficient evidence to
reject showing that ordinal regression using the log-log function is appropriate for these
data.
My intention for research question four was to determine if there was a significant
relationship between older adult participants’ perceived barriers and discouragement
concerning the uptake of the seasonal influenza vaccine.
4. Is there a significant relationship between older adults’ perceived barriers and
discouragement concerning the uptake of the seasonal influenza vaccine?
H40: There no significant relationship between older adults perceived barriers and
discouragement concerning the uptake of the seasonal influenza vaccine. This
hypothesis was not supported and was rejected.
H4A: There is a significant relationship between older adults’ perceived barriers
and discouragement concerning the uptake seasonal influenza vaccine. This
hypothesis is supported as the dependent variables and the benefit construct relate
to each other.
Findings indicate that there is a significant relationship between the perceived
barriers and the dependent variable recency of influenza vaccine questions. Ordinal
regression statistics were run between this construct and the dependent variable recency
of influenza vaccine uptake. The model fit null hypothesis can be rejected as the observed
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significance for the perceived benefits construct and self-efficacy construct resulted in a p
= .002 and the benefit construct and cues to action resulted in a p =.000.
The parallel lines for barrier question in this section were tested using the
predictor variables severity, cues to action and self-efficacy. The null hypothesis of
parallelism for benefit and cues to action, (p = .000, -2 log likelihood 382.944) does have
sufficient evidence to reject showing that ordinal regression using the log-log function
may not be appropriate for these data. However, the null hypothesis of parallelism for
benefit and self-efficacy, (p = .972, -2 log likelihood 130.160) do not have sufficient
evidence to reject showing that ordinal regression using the log-log function is
appropriate for these data.
My intention for research question five was to determine if there was a significant
relationship between older adult participants’ perception perceived cues to action and
health care providers providing persuasive communications about seasonal influenza
vaccine.
5. Is there a significant relationship between older adults’ perceived cues to action and
health care providers’ persuasive communications about seasonal influenza vaccine?
H50: There is no significant relationship between older adults’ perceived cues to
action and health care providers’ persuasive communications about seasonal
influenza vaccine. This hypothesis was not supported and was rejected
H5A: There is a significant relationship between older adults’ perceived cues to
action and health care providers’ persuasive communications about seasonal
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influenza vaccine. This hypothesis was supported based on the following
results.
Examination of the data suggests that there is a significant relation between the
cues to action construct questions and the dependent variable questions. Ordinal
regression statistics were run between this construct, cues to action and self-efficacy and
the dependent variable recency to influenza vaccine constructs. The model fit null
hypothesis can be rejected as the observed significance for the barriers construct and selfefficacy construct resulted in a p = .000 and the barriers construct and cue to act resulted
in a p = .000.
The parallel lines for cues to action question in this section were tested using the
predictor variables barriers, and self-efficacy. The null hypothesis of parallelism for
barriers and cues to action, (p = 1.000, -2 log likelihood 250.243) do not have sufficient
evidence to reject showing that ordinal regression using the log-log function is
appropriate for these data. The null hypothesis of parallelism for barriers and selfefficacy, (p = 1.000, -2 log likelihood 267.924) do not have sufficient evidence to reject
showing that ordinal regression using the log-log function is appropriate for these data.
My intention for research question six was to determine if there was a significant
relationship between older adult participants’ perception of perceived self-efficacy and
the ability to successfully obtain the seasonal influenza vaccine.
6. Is there a significant relationship between older adults’ perceived self-efficacy and the
ability to successfully obtaining the seasonal influenza vaccine?
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H60: There is no significant relationship between older adults’ perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
This hypothesis is not supported and was rejected.
H6A: There is a significant relationship between older adults’ perceived selfefficacy and the ability to successfully obtaining the seasonal influenza vaccine.
This hypothesis was supported based on the following results.
Examination of the data suggests that there are significant associations between
the self-efficacy construct questions, and the dependent variable questions. Ordinal
regression statistics were run between the six constructs of the HBM and the dependent
variable recency of influenza vaccine uptake. The model fit null hypothesis can be
rejected as the observed significance for the barriers construct and self-efficacy construct
resulted in a p = .000 and the barriers construct and cues to action resulted in a p = .000.
The parallel lines for self-efficacy question in this section were tested using the
predictor variables barriers and cues to action. The null hypothesis of parallelism for
barriers and cues to action, (p = 1.000, -2 log likelihood 244.225) do not have sufficient
evidence to reject showing that ordinal regression using the log-log function is
appropriate for these data. The null hypothesis of parallelism for barriers and selfefficacy, (p = 1.000, -2 log likelihood 269.920) do not have sufficient evidence to reject
showing that ordinal regression using the log-log function is appropriate for these data.
My intention for research question seven was to determine whether there was a
significant relationship between older adult participants’ perception between the full
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HBM constructs plus mediating demographic factors such as age, gender, ethnicity,
occupation and older adults’ perceptions of the seasonal influenza vaccine.
7. Is there a significant relationship between full HBM constructs plus mediating
demographic factors such as age, gender, ethnicity, occupation, and older adults’
perceptions of the seasonal influenza vaccine?
H70: There is no significant relationship between full HBM constructs plus
mediating demographic factors such as age, gender, ethnicity, occupation, and
older adults’ perceptions of the seasonal influenza vaccine. This hypothesis was
not supported and was rejected.
H7A: There is a significant relationship between full HBM constructs plus
mediating demographic factors such as such as age, gender, ethnicity, occupation,
and the elderly perceptions of acceptance of the seasonal influenza vaccine. This
hypothesis was supported based on the following results.
Examination of the data suggests that there are significant associations between
the mediating factor age and dependent variable frequency of influenza disease questions.
Ordinal regression statistics were run between this construct and the dependent variable
and age. The model fit for the null hypothesis can be rejected as the observed significance
for age construct resulted in a p = .000.
The parallel lines for mediating factor age question in this section were tested
using the predictor variables barriers, cues to action and self-efficacy. The null hypothesis
of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood 248.125) do
not have sufficient evidence to reject showing that ordinal regression using the log-log
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function is appropriate for these data. The null hypothesis of parallelism for barriers and
self-efficacy, (p = 1.000, -2 log likelihood 272.936) do not have sufficient evidence to
reject showing that ordinal regression using the log-log function is appropriate for these
data.
My intention for research question eight was to determine whether there was a
significant relationship between older adult participants’ perception influenza disease and
recency and influenza vaccine uptake.
8. Is there significant relationship between influenza vaccine recency and influenza
disease among older adults?
H80: There is no significant relationship between influenza vaccine recency and
influenza disease among older adults. This hypothesis was not supported
based on the following results.
H8A: There is a significant relationship between influenza vaccine recency and
influenza disease among older adults. This hypothesis was supported based
on the following results.
Examination of the data suggests that there are significant associations between
the six HBM constructs and dependent variable recency of influenza vaccine uptake.
Ordinal regression statistics were run between the HBM constructs and the dependent
recency of influenza vaccine uptake. The model fit null hypothesis can be rejected as the
observed significance for health belief constructs resulted in a p = .000.
The parallel lines for recency of influenza vaccine question in this section were
tested using the predictor variables barriers, cues to action and self-efficacy. The null
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hypothesis of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood
242.340) do not have sufficient evidence to reject showing that ordinal regression using
the log-log function is appropriate for these data. The null hypothesis of parallelism for
self-efficacy (p = 1.000, -2 log likelihood 272.926) do not have sufficient evidence to
reject showing that ordinal regression using the log-log function is appropriate for these
data.
My intention for research question nine was to determine whether there was a
significant relationship between influenza disease frequency and influenza vaccine
uptake and older adults.
9. Is there a significant relationship between influenza disease frequency and influenza
vaccine uptake among older adults?
H90: There is no significant relationship between influenza disease
frequency and influenza vaccine uptake among older adults. This hypothesis
is not supported and was rejected.
H9A: There is a significant relationship between influenza disease frequency
and influenza vaccine uptake among older adults. This hypothesis is
supported based on the following results.
Examination of the data suggests that there are significant associations between
the mediating factor age and dependent variable frequency of influenza disease. Ordinal
regression statistics were run between this construct and the dependent variable and age.
The model fit for the null hypothesis can be rejected as the observed significance for age
construct resulted in a p = .000.
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The parallel lines for frequency of influenza disease question in this section were
tested using the predictor variables barriers, cues to action and self-efficacy. The null
hypothesis of parallelism for barriers and cues to action, (p = 1.000, -2 log likelihood
248.326) do not have sufficient evidence to reject showing that ordinal regression using
the log-log function is appropriate for these data. The null hypothesis of parallelism for
barriers and self-efficacy, (p = 1.000, -2 log likelihood 272.926) do not have sufficient
evidence to reject showing that ordinal regression using the log-log function is
appropriate for these data.
Summary and Transition
In this section I have summarized the answers to research questions, provided
transitional material from the findings and introduced the materials used in Chapter 5.
The results of this study indicate that older adults’ subjective agreement of their influenza
vaccine uptake statements are related to their perceptions of benefits from the influenza
vaccine. The test-retest results showed reliability of the instrument was consistent and
stable across time and testing. The nine research questions were investigated using factor
analysis, computed means, reliability and ordinal regression. Factor analysis was
appropriate for these data, which indicated that the factors were related to the dependent
variables. Cronbach’s alphas were significant in the reliability testing for all constructs.
Construct items were grouped into subscales by computing means, based on factor
analysis, prior to ordinal regression analysis. Hypothesis testing was done based on the
review of the literature, which indicated that to minimize barriers to influenza vaccine
uptake, the clinicians’ role is to remind patients about the influenza vaccine safety and
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effectiveness in preventing influenza disease and its complications. Despite variations in
the test of parallel lines the null hypotheses were rejected. The nine alternative
hypotheses were retained. Chapter 5 further explains the summary of the interpretation of
these findings, generalizations, limitations, social implications of the study, and
recommendations for future studies.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to identify perceived factors that may be associated
with poor influenza vaccination uptake among older adults. I also explored recency of
influenza vaccine uptake and frequency of influenza disease within the past year. In this
chapter, I discuss the interpretation of key findings, generalizations, limitations,
recommendations for future studies, and implications for practice and social change.
The study was carried out in three senior centers in Brooklyn, New York. The
overall number of elderly participants who responded to the survey invitation was 147.
The results indicated that 92% of older adults received the seasonal influenza during the
2014/2015 flu season. This high vaccination uptake could be the success of influenza
vaccination campaigns and the extensive media education regarding the influenza related
deaths in the United States and around the world. I found that perceptions of cues to
action, such as healthcare provider reminders, were more likely to influence those older
adult participants who had prior vaccination. Partners from the CDC’s 2011-12 Influenza
Vaccination Communication Campaign reported that 80 % of participants were likely to
take the influenza vaccine due to media education while 19% were less likely to take the
influenza vaccine (as cited in Sheedy, 2011). There is evidence on the effectiveness of
interventions that apply new social media such as text messaging, smartphones
application, YouTube videos, and Facebook (Odone, 2015). Targeted websites and
portals for physicians and healthcare providers promoted vaccination uptake and
increased vaccination coverage (Odone, 2015). According to Odone (2015), the
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effectiveness of vaccine uptake using these new media sources are as follows: text
messaging (37%), smartphone applications (5%), YouTube videos (5%), and Facebook
(5%), targeted websites and portals (21%), software for physicians and health
professionals (21%), and email communication (5%). In addition, the current reminder
from health care providers (90%) has a significant effect on older adult participants
perceived behaviors concerning vaccine uptake (Odone. 2015).
Interpretation of the Findings
In this section, I present whether the study findings confirm, disconfirm, or extend
knowledge in the discipline in comparison to current literature. A main goal of the study
was the development of a new instrument. Evidence from factor analysis is discussed in
terms of reliability and constructs validity of the questionnaire. In addition, the analysis
and interpretation of the findings are presented based on the conceptual framework.
Factor analysis and correlations were performed to analyze the reliability
(test/retest) of the newly developed scale and findings indicated that the new scale had a
reliability coefficient (r2 = 0.9) calculated from the data for the first group that indicated
high test-retest reliability. Factor analysis verified the constructs of the new scale by
calculating Cronbach’s alphas.
Previous literature indicated racial and ethnic differences in beliefs where whites
were more likely to believe the influenza vaccine was very effective in preventing
influenza compared to African Americans (Blacks) and Hispanics (Wooten, Wortley,
Singleton, & Euler, 2012). In the present study, the odds of influenza vaccine uptake
indicated that there were no significant differences between European Americans
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(Whites), African Americans, or Hispanics concerning influenza vaccine uptake (OR =
1.20, 95% CI [0.64, 2.30], p =.58). Zimmerman, Raymund, Janosky, Norwalk, and Fine
(2003) compared self-report with medical record abstraction of older adults in several
locations. Their findings indicated that Veterans Association patients had the highest
sensitivity and lowest specificity for both influenza and pneumococcal vaccines. While
over 90% of the responders stated they had vaccine uptake, verification from medical
records indicated that only 51% had received the vaccine. The opposite was true for
inner-city health centers. The findings from the homogeneous senior center participants
are likely to reflect these two types of health centers; however, the associations between
self-reported perceptions and vaccination uptake in the present study remain stable.
Older adult participants believed that the influenza vaccine is very effective; selfreported vaccination was substantially higher across all racial/ethnic groups. To identify
older adults perceived behaviors that contributed to poor uptake of the seasonal influenza
vaccine among older adults, I developed nine research questions, a 33-item tool using the
HBM to explore the perception of the older adults concerning the seasonal influenza
vaccine uptake, demographic mediating factors, frequency of the influenza disease, and
recency of influenza vaccine uptake. In this study, the ordinal regression revealed that
there were significant correlations between older adults’ perceptions of the influenza
disease and influenza vaccine uptake (p = 0.05).
Research Question 1: Perceived Susceptibility
Ordinal regression analysis was performed to answer this research question.
Perception of influenza infection risk was significant as a predictor for older adult

105

participants. Older adults who believed that they were at greater risk for contracting
influenza were more likely to obtain influenza vaccination. This finding addresses the
construct of perceived susceptibility, where it refers to an individual’s beliefs about the
chances of getting a condition (Glanz et al., 1997; NCI, 2005). The computed sample
mean for the specific perceived susceptibility was 5.24. Most participants agreed or
strongly agreed with the items related to the risk of contracting seasonal influenza. The
results of the ordinal regression showed that there were significant correlations between
the perceived susceptibility and predictor variables cues to action and self-efficacy and
dependent variables recency of influenza vaccine and frequency of influenza disease.
Yamamoto et al. (2002) reported that perceived threat and net benefit were associated
with intention, and net benefit had a stronger correlation with intention than did perceived
benefit and barriers. In this study, I found that older adults agreed or strongly agreed
with the susceptibility of influenza infection items.
Research Question 2: Perceived Severity
Perceived severity is an individual’s belief about the seriousness of influenza and
its prevention (Glanz, K., Rimer, B.K. & Lewis, 2002). Ordinal regression analysis was
run on each independent variable: susceptibility, severity, benefits, barriers, cues to
action, self-efficacy, and the demographic modifying factors as well as the dependent
variables: perceived recency of influenza vaccine uptake and frequency of influenza
disease. Perception of the seriousness of influenza disease was found to be significant as
a predictor of older adults’ uptake of the influenza vaccine. This finding indicated that
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perceptions of the seriousness of influenza disease and its complications correlated with
most of the other predictor variables as well as the two dependent variables.
My findings confirm that the extent of knowledge and awareness of influenza
disease and vaccine availability contributed to the importance of influenza vaccine uptake
among the elderly when comparing them with reports found in the peer-reviewed
literature. The computed sample mean for the specific seriousness construct was 5.5.
Most participants agreed or strongly agreed with the items related to the seriousness of
influenza disease. Items that addressed the perceived seriousness of contracting seasonal
influenza disease showed that a higher percentage of vaccinated older adults believed that
influenza was a serious concern. Ordinal regression was performed, and it was identified
that there were significant correlations. This finding is not consistent with the current
literature. Maurer et al. (2010) reported that perceived seriousness of seasonal influenza
and swine flu risks in adults revealed that swine flu was believed to be more serious and
therefore the uptake of vaccination was lower due to perception by the public who
believes it was less safe. However, the current study suggests that older adults were more
likely to consider seasonal influenza as a serious illness that would negatively affect their
everyday functioning and quality of life.
Research Question 3: Perceived Barriers
Perceived barriers to influenza immunization is the belief about the influenza
vaccine and psychological costs of taking the vaccine (Glanz, Rimer, & Lewis, 2002).
Ordinal regression analysis was used to answer the perceived barrier construct. The
perception of the barriers of the influenza vaccine was found to be a significant predictor
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in addressing influenza vaccine uptake among older adults. This finding indicated that the
perceptions of the barriers of influenza vaccine was with most related to predictor
variables benefits, cues to action, self-efficacy, as well as the two dependent variables
recency of influenza vaccine and frequency of influenza disease. When comparing results
with what has been found in the peer-reviewed literature, it was identified that my
findings confirm some of the existing literature. The computed sample mean for the
specific barriers construct was 4.60, where most participants disagreed or strongly
disagreed with the items related to the barriers of influenza vaccine. However, the ordinal
regression was found to have significant correlations. This is consistent with the current
literature in relation to the barriers. Johnson et al. (2008) reported that among the most
common barriers to immunizations were lack of physician recommendations and
mistaken assumptions while other reasons cited by healthcare providers were side effects,
fear of needles, and lack of insurance coverage as reasons and practice issues, such as a
lack of an effective reminder system.
Research Question 4: Perceived Benefit
Perceived benefit is the belief about the effectiveness of taking the influenza
vaccine to reduce risk of getting influenza and the related complication (Glanz, Rimer, &
Lewis, 2002). Ordinal regression analysis was done to answer research question,
perceived benefit. Perception of the benefit of addressing the influenza vaccine was
found to be significant as a predictor of elderly participants’ uptake of the influenza
vaccine. This finding is not surprising given that perceptions of the benefit of influenza
vaccine correlated with predictor variables, barriers, cues to action, and self-efficacy, as
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well as the two dependent variables of recency of influenza vaccine uptake and frequency
of influenza disease.
My findings extend knowledge in the discipline when comparing them with what
has been found in the peer-reviewed literature. The computed sample mean for the
specific benefit construct was 5.42, where most participants agreed or strongly agreed
with the items related to the benefit of influenza. Ordinal regression showed that there
were significant correlations. This is consistent with the literature that reported on
perceived benefits of the influenza vaccination due to the prevention of the seasonal
influenza disease, decreased severity of symptoms, less time off, a lower chance of
passing influenza to family and friends, and prevention of complication and hospital
admission. Chen et al. (2007) supported the contention that groups with major long-term
conditions, women, older people, and those who have needed or are likely to require
hospital admission are more likely to decide to receive an annual influenza vaccination.
Research Question 5: Perceived Cues to Action
Cues to action are strategies to activate readiness (Janz & Becker, 1984) that can
be described as events, either bodily symptoms such as physical symptoms of a health
condition or environmental such as media publicity that motivate people to take an
action. Ordinal regression analysis was done to answer perceived cues to action construct.
Perception of the cues to action of the influenza vaccine was found to be significant as a
predictor in addressing influenza vaccine uptake among the elderly. This finding
indicated that perceptions of the cues to action of influenza vaccine was most related to
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predictor variables barriers, benefits, and self-efficacy as well as the two dependent
variables recency of influenza vaccine and frequency of influenza disease.
When comparing results with what has been found in the peer-reviewed literature,
it was identified that my findings confirm some of the existing literature. Physician and
other clinicians’ recommendations and reminder systems for the influenza vaccine are
known to increase vaccination rates significantly (Anderson et al., 2008). The computed
sample mean for the specific cues to action construct was 5.60, where most participants
agreed or strongly agreed with the items related to the cues to action of influenza vaccine
uptake. The ordinal regression was found to have significant correlations.
Research Question 6: Perceived Self-Efficacy
Perceived self-efficacy is the confidence and the ability to successfully make
informed decisions (Glanz et al., 2002). Ordinal regression analysis was carried out to
answer perceived self-efficacy construct. Perception of the perceived self-efficacy of the
influenza vaccine was found to be significant as a predictor in addressing influenza
vaccine uptake among older adults. This finding indicated that perceptions of the
perceived self-efficacy concerning the influenza vaccine uptake was most related to
predictor variables barriers, benefits, and cues to action as well as the two dependent
variables recency of influenza vaccine and frequency of influenza disease.
Findings confirm those of Zimmerman et al. (2003) who concluded that patient
education and recommendation for the influenza vaccination by healthcare providers
increases likelihood of patient vaccination uptake by eliminating misconceptions,
vaccine-related concerns, and myths. The computed sample mean for the specific self-
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efficacy construct was 5.64, where most participants agreed or strongly agreed with the
items related to the self-efficacy of influenza vaccine uptake. The ordinal regression was
found to have significant correlations.
Research Question 7: Demographic Mediating Factors
Demographics mediating factors in this study found that the vaccinated were not
statistically different with regards to most of the demographic variables: gender, age,
ethnicity, education, annual income, and type of residence. Evidence for the clinical
efficacy of the influenza vaccine among the older adults, especially those with chronic
disease, can reduce mortality and hospital admissions (CDC, 2013). Mediating factor age
was tested using the six HBM predictor variables: susceptibility, severity, barriers,
benefit, cues to action, and self-efficacy. Ordinal regression statistics were run between
the six HBM subscales, which indicated that there were no statistical significant
differences across age groups of older adults, resulting at a 5% significance level.
However, there are significant associations between the mediating factor age and
dependent variable of frequency of influenza disease. When comparing results with what
has been found in the peer-reviewed literature, it was identified that my findings confirm
some of the existing literature concerning the importance of influenza vaccine among the
elderly. Johnson et al. (2008) reported that by counseling older adult patients and by
acknowledging their fear and susceptibility to influenza, it can help them to make
changes in their behavior that will motivate them to make informed decisions.
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Research Question 8: Frequency of Influenza Disease
Frequency of influenza disease refers to measurement of the most recent episode
of influenza disease 1 = ≤1 year (CDC, 2013). Logistic regression analysis was used to
answer research question about frequency of influenza infection. Research questions
predicting frequency of influenza infection were tested using the six HBM constructs:
severity, susceptibility, barriers, benefits, cues to action, and self-efficacy. Ordinal
regression was run using predictor variables barriers, benefits, cues to action, and selfefficacy. There was not sufficient evidence to reject the null hypothesis. Ordinal
regression statistics were run between frequency of influenza disease and age, and the
null hypothesis was rejected because it indicated that age makes no difference. When
comparing results with what has been found in the peer-reviewed literature, it was
identified that my findings confirm some of the existing literature. Studies have shown
that older adults who had received the influenza vaccine in a year or less had a decreased
incidence in influenza and its complication (CDC, 2010).
Research Question 9: Recency of Influenza Vaccine Uptake
Recency of influenza vaccine uptake refers to measurement of the most recent
influenza vaccine uptake. Ideal = (1 = ≤ 1 year) (CDC, 2013). Logistic regression
analysis was used to answer research question recency of influenza vaccine uptake. The
recency of influenza vaccine question were tested using the six construct of the HBM,
severity, susceptibility, barriers, cues to action and self-efficacy. Ordinal regression was
run using predictor variables barriers, cues to action and self-efficacy. There was not
sufficient evidence to reject the null hypothesis. When comparing results with what has
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been found in the peer-reviewed literature it was identified that my findings confirms
some of the existing literature. Studies have shown that recency of influenza vaccine
uptake within one year or less has proven to be safe and effective in preventing influenza
infection and its complication among the elderly (CDC, 2010). Studies have reported that
there is an age-related decline in immune responses in older adults causing a greater
susceptibility to infection and reduced responses to vaccination (Skowronski, Tweed,
Serres, 2008). Other studies have indicated that a low protective effect of the influenza
vaccine suggest a decline in vaccine effectiveness in older adults over time post
vaccination therefore annual influenza immunization of high-risk populations against
influenza remains the most important preventive method (Castilla, Martinez-Baz,
Martinez-Artola, et al., 2013).
Limitations
In every study, there is a possibility of limitations. Since this study uses a crosssectional design, there can be limitations with the strength of the internal validity. The
study was also limited to self-report of seasonal influenza vaccination status, truthfulness
of participant’s responses, either because they cannot remember or because they wish to
present themselves in a socially desirable manner. In addition, external validity is a
limitation as data on disease diagnosis and vaccination uptake was limited to selfadministration without verification of medical records. Due to the nonrandom selection of
participants, the study was limited by self-selection of volunteer male and female adults
age 65 and older who attended the selected senior centers Brooklyn, New York.
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The possible biases that could influence study outcomes are those due to nonresponse. To minimize this type of bias the sample size was large enough to estimate the
prevalence of the influenza vaccine uptake among the elderly in the selected demographic
areas of Brooklyn. A potential limitation is that the study did not use random sampling
and the results may not be generalizable to all older adult population hesitant to receive
the seasonal influenza vaccination. However, the development of a new instrument
required quick and high participation from a homogeneous population.
Recommendations
The recommendations for further research that are grounded in the strengths and
limitations of the current study, as well as the current literature are discussed in this
section. The following are the recommendations for further studies:
● Additional studies should be done on more specific correlations related to older
adults’ perceptions in both controlled and uncontrolled community settings.
● Research using a random selection of elderly in the community involving recency
of influenza immunization uptake and frequency of influenza disease within one
year or less.
● Future studies should further examine the effectiveness of structured influenza
vaccine interventions such as physicians and other clinician reminders, television
advertising, targeting social media networks, and community organizations.
● Get family members more involved by asking them to get vaccinated or to
accompany older adult family members to vaccine sites.

114

These recommendations can help provide future researchers, public health
professionals and healthcare clinicians to work together to increase influenza vaccination
rates in the general population.
Implications for Social Change
Positive social change that can be derived from this study is identifying the gap in
knowledge related to direct care clinicians concerning the importance of influenza
vaccine and the contributory aspects in reducing the influenza complication among older
adults. Although the constructs perceived susceptibility, seriousness and barriers may
contribute to difficulties accepting influenza vaccination; clinicians can make a difference
by teaching their patients about safety and effectiveness of the seasonal influenza
vaccine. In this study the constructs benefit, cues to action and self-efficacy were
determinants that made a positive difference in the perceived older adults’ beliefs about
seasonal influenza vaccination uptake. This research captured the perceptions of the older
adults concerning their perceived belief about influenza disease and gave a better
understanding that the influenza vaccine uptake among older adults can be improved
through education and information received from the clinicians. This information can
also help clinicians and public health officials to be more involved in educational
seminars and follow CDC (CDC, 2014) and evidence based guidelines to improve the
seasonal influenza vaccine uptake among older adults. The HBM can also be a useful tool
in understanding beliefs and perceptions of older adults concerning influenza vaccination
and guide the choice of the clinical interventions for elderly patients who either directly
or indirectly oppose the influenza vaccination (Glanz, Marcus Lewis, & Rimer, 1997).
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Practice Recommendations
Recommendations for practice include increasing knowledge and awareness of
clinicians by addressing methods of informing their patients during health visits;
clinicians must also overcome their own barriers that prohibit influenza vaccine uptake;
and also, making clinicians more aware of their roles in influenza prevention. Most
importantly, review of health policies based on the risk factors of influenza disease,
severity, evidence of the influenza vaccine safety, efficacy, and the effectiveness in
preventing influenza complication among the older adults can improve vaccine uptake.
The results of this study lead us to believe that clinicians understanding of current health
policies and patients’ perceptions of influenza vaccine can lead to improvement in
clinical practice and standards of care.
Conclusion
This research captured the perceptions of the older adults concerning their
perceived belief about influenza disease and gave a better understanding that the
influenza vaccine uptake among older adults can be improved through education and
information received from the clinicians. The significance of the findings suggest older
adults’ perception of seasonal influenza disease and vaccine uptake as a method of
prevention and its association with clinical practice in raising awareness about the safety
and effectiveness of the influenza vaccine. In this study, I examined the perceptions of
older adults concerning the influenza vaccine uptake which was below the national
average. To increase vaccination uptake among older adults, this research suggests there
is a need to address health beliefs, influenza vaccine side effects, safety and effectiveness.
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The results of this study support the need for continued patient and clinician education,
and awareness of effective guidelines that support influenza vaccine uptake among older
adults. The data indicate that older adults’ perception of the seriousness, susceptibility
and barriers, are triggered by predictors including perceived benefits, cues to action and
self-efficacy. These findings support clinical strategies that promote the influenza
vaccination uptake. Implementing more clinicians’ reminders and media campaigns
especially during the influenza season can be an asset in improving influenza vaccine
uptake.
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Appendix A: Expert Panel Recruitment Letter
I am working on my dissertation related to Correlates of Influenza Vaccine
Uptake Among the Elderly and need an expert panel to review my newly created survey. I
am looking for professionals that have either academic background in content or
methodology expertise, have research experience in healthcare, or practice as a medical
doctor or nurse practitioner. I am reaching out to you as I feel you meet one of these
criteria and I feel you would be a vital asset to my expert panel.
As a member of an expert panel you receive all the information the typical study
participant will receive and provide comments on the items in the survey. I will ask you
to look strictly at the content of the survey and wording of the questions/statements and
not the format of the survey. The official survey format will be done on a Word
document which you will review. You would add comments where you feel changes are
needed on the form available titled “Form for Review and Evaluation of Validity and
Reliability by a Panel of Experts for Quantitative Instrumentation of “Older Adults
Perceptions of Influenza Disease and Influenza Vaccine Uptake”. I may ask you to
review revisions made based on the comments received, however I will try to get these
back to you within 7 to 10 days. The survey and form are attached above for you to
review.
Thank you for your time and consideration.
I have also attached my Curriculum Vitae for information on my background.
Sincerely,
Cheryl Hilliman, RN, MSN, FNP, WCCN
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Appendix B: Panel of Experts Review Form
Form for Review and Evaluation of Validity and Reliability by a Panel of Experts for
Quantitative Instrumentation of Elderly Perceptions of Influenza Disease and Influenza
Vaccine Uptake
Instructions: Please review the attached Quantitative Instrumentation of Elderly
Perceptions of Influenza Disease and Influenza Vaccine Uptake and respond to the
following questions regarding the construction, validity and potential reliability for the
Quantitative Elderly Perceptions of Influenza Disease and Influenza Vaccine Uptake
concerning the phenomenon being researched, examined, assessed, evaluated or
measured.
Section I. VALIDITY EVALUATION
A test, survey, questionnaire, evaluation or assessment instrument is valid to the extent
that the instrument measures the construct(s) that the instrument purports to measure.
1. Instrument Construction:
1. (a). Are the instructions for completing the instrument clear?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
1.(b). Is the application and results of the Quantitative Instrumentation of Elderly
Perceptions of Influenza Disease and Influenza Vaccine Uptake adequately reflected in
this instrument?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
1. (c). What items would you add?
1. (d). What items would you delete?
2. Content Validity:
Will the scores yielded by Quantitative Instrumentation of Older Adults Perceptions of
Influenza Disease and Influenza Vaccine Uptake adequately represent the content or
conceptual domain of the construct being measured? In other words, does the instrument
have adequate and appropriate items that constitute a representative sample of the
complete domain of items used to generalize the construct being measured? Please see
the attached table of specifications [instrument blueprint] that reflect which items and
how many items within the instrument are designed to measure each type of content
domain.
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
3. Construct Validity:
Quantitative Instrumentation Older Adults Perceptions of Influenza Disease and
Influenza Vaccine Uptake is designed to measure Older Adults Perceptions of Influenza
Disease and Influenza Vaccine Uptake, Recency of influenza vaccine uptake= (1=≤1
year) and Frequency of Influenza disease = (1=≤1 year). Please see constructs definition:

147

Insert of constructs definition based on Glanz, K., Marcus Lewis, F. & Rimer, B.K. 1997;
Rosenstock, Strecher, Becker, 1988. The health belief model has six constructs and the
mediating demographic factors which support the six constructs, and its underlying
concept is that health behavior is determined by a person’s beliefs or perceptions about
influenza disease and vaccine uptake and techniques to decrease influenza disease
among older adults. The main constructs are perceived susceptibility, severity, benefits,
barriers, cues to action, self-efficacy and the mediating demographic factors which
supports the six core perceived concepts. Perceived susceptibility evaluates the
perception of the risk of developing the influenza disease and lends to the motivation to
take the influenza vaccine to decrease that risk of getting influenza disease. The construct
of perceived severity evaluates individual's beliefs about the seriousness of influenza
disease and how to avoid it. Perceived benefit evaluates the participants’ beliefs about
the chances of getting influenza disease and the potential positive impact of the uptake of
the influenza vaccine to decrease the risk of influenza disease. Perceived barriers
evaluates participants’ opinion of what is stopping them from making the decision to
adopt a new behavior that can protect and prevent influenza disease. Self-efficacy
evaluates the participants’ perception of their competence to successfully act in seeking
the influenza vaccine. Demographic mediating factors are the modifying variables such
as age, sex, race, ethnicity, and education that may interfere influenza vaccine uptake
indirectly by affecting perceived susceptibility, benefits, barriers, cues to action and selfefficacy. Recency of influenza is evaluated by measuring the most recent influenza
vaccine uptake. Ideal = (1=≤1 year).
3. (a) Does the Quantitative Instrumentation of Elderly Perceptions of Influenza Disease
and Influenza Vaccine Uptake represent concepts or constructs it should represent and
does not represent concepts it should not represent? In other words, does the Quantitative
Instrumentation of Older Adults Perceptions of Influenza Disease and Influenza Vaccine
Uptake adequately represent the constructs it purports to represent?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
3. (b) Is the Quantitative Instrumentation of Older Adults Perceptions of Influenza
Disease and Influenza Vaccine Uptake inclusive of the important dimensions or facets of
the constructs it purports to measure.
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
3. (c) Does the Quantitative Instrumentation of Older Adults Perceptions of Influenza
Disease and Influenza Vaccine Uptake avoid excess reliable variance, ensuring no items
are easier or harder for some respondents in a manner relevant to the interpreted
construct?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
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D. Face Validity
Does the Quantitative Instrumentation of Older Adults Perceptions of Influenza Disease
and Influenza Vaccine Uptake look valid? Does it appear to represent a measure of the
construct it purports to measure?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
E. Item Bias
Does the wording or placement of an item avoid affecting someone’s response?
(This includes the avoidance of double-barreled items, words or phrases, which raise
emotional red flags, ambiguous wording, gender bias, racial/ethnic bias, and the
manipulative placement of an item or wording of an item)
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
F. Consequential Validity
Does the Quantitative Instrumentation of Elderly Perceptions of Influenza Disease and
Influenza Vaccine Uptake instrument embody desirable values and have potentially
positive consequences for the discipline or field it reflects?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
Section II. RELIABILITY EVALUATION
A test, survey, questionnaire, evaluation or assessment instrument is reliable to the extent
that whatever construct(s) the instrument measures, it measures the construct(s)
consistently.
A. Internal Consistency
Are the items that make up the Quantitative Instrumentation of Older Adults Perceptions
of Influenza Disease and Influenza Vaccine Uptake internally consistent with each
component and/or the constructs being examined, assessed, evaluated or measured?
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
B. Potential for Reliability (Potential for Consistent Responses)
Understanding that research participants completing this instrument will vary in their
understanding and experience with the Older Adults Perceptions of Influenza Disease
and Influenza Vaccine Uptake and thus vary in their responses, is there anything about
this instrument that would lead you to believe that this instrument would not consistently
measure Older Adults Perceptions of Influenza Disease and Influenza Vaccine Uptake.
[ ]
Yes
[ ]
No (if no, please explain)
[ ]
Yes provided the following actions are taken:
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Please provide any additional comments, suggestions for improvement, and/or any other
thoughts regarding the construction, how the survey to be easier to complete, validity
and/or reliability of the Quantitative Instrumentation of Older Adults Perceptions of
Influenza Disease and Influenza Vaccine Uptake

Panel Member
Printed or typed Name:
Title:
Department:
Organization:
Location:
Signature: ____________________________

Date: ______________________
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Appendix C: Community Research Partner Review Form
Community Research Partner Name:
Contact Information
Date
Dear Cheryl Hilliman,
Based on my review of your research proposal, I give permission for you to conduct the
study entitled “Correlates of Influenza Vaccination Uptake among the Older Adults”
within the Christopher C. Blenman Senior Center. As part of this study, I authorize you
to recruit all (a) men and women, (b) age 65 years and older, (c) English speaking, (d)
oriented to person, time and place, (e) members of the selected senior citizen centers and
(f) able to read and understand the English language to be in the study. Individuals’
participation will be voluntary and at their own discretion. The purpose of the survey is
to identify perceived factors that may be associated with poor influenza vaccination
uptake among the older adults. The information that is collected will be analyzed and
added to the future knowledge of how to Identify:
● Strategies for maintaining and sustaining change related to increasing influenza
vaccine uptake; and
● Future implications of using the Health Belief Model to assess the perception and
beliefs of the older adults’ population especially in Brooklyn, New York.
We understand that our organization’s responsibilities include: a secure area which will
be allocated to you to complete the survey. We reserve the right to withdraw from the
study at any time if our circumstances change.
I will be complying with your site’s research policies and requirements, including
participants’ safety and confidentiality.
I confirm that I am authorized to approve research in this setting and that this plan
complies with the organization’s policies.
I understand that the data collected will remain entirely confidential and may not be
provided to anyone outside of the student’s supervising faculty/staff without permission
from the Walden University IRB.
Sincerely,
Authorization Official
Contact Information
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Appendix D: Survey Rating Form
Survey Rating Form
This survey explores the perception related to influenza vaccine uptake among the
elderly. Participation in this survey is completely voluntary. Your answers to each
question is important, so please complete each item on the form to the best of your
ability. Your responses must be honest. Each item to the concept of health belief model
on the survey must be read carefully and answered by selecting one of the numbers on the
5-point scale that represents how relevant you believe it is measuring the concept of the
perceived action. All the information you provided will help clinicians to develop better
influenza vaccine programs for the elderly in the future.
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ITEMS

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.

17.
18.
19.

20.
21.
22.
23.

24.

25.

If I get the seasonal influenza virus I will get sick.
If I get the seasonal influenza virus I will lose
income.
If I get the seasonal influenza virus other members
in my home will get sick.
If I get the seasonal influenza virus I will die
I am at risk for getting the seasonal influenza virus
My family members are at risk for getting the
seasonal influenza virus.
I feel knowledgeable about my risk of getting the
seasonal influenza virus.
I will have side effects from the seasonal influenza
vaccine.
I will get sick from the seasonal influenza vaccine.
I will die from the seasonal influenza vaccine.
The seasonal influenza vaccine will be painful.
The seasonal influenza vaccine will be expensive.
It is inconvenient to get the seasonal influenza
Vaccine
There is a shortage of the seasonal influenza
vaccine
If I receive the seasonal influenza vaccine, I will
not get sick from the seasonal influenza virus
If I receive the seasonal influenza vaccine it will
prevent complications from the seasonal influenza
disease
Seasonal influenza vaccines are safe.
I will take the seasonal influenza vaccine if my
doctor or my nurse said it is important
I will take the seasonal influenza vaccine if a
family member or significant other said it is
important
I will take the seasonal influenza vaccine if I see a
TV ad that said it is important
I will take the seasonal influenza vaccine if the
interdisciplinary team at my clinic reminds me.
I am confident that I can obtain the seasonal
influenza vaccine
I am confident that my day to day performance will
not be adversely impacted by taking the seasonal
influenza vaccine
I am confident that the seasonal influenza vaccine I
will take will not exposed me to any side effects or
death
I am confident that seasonal influenza vaccine will
help to prevent me from getting the seasonal
influenza throughout the influenza season.

1.
Strongly
Disagree

2.
Disagree

4.
Agree

5.
Strongly
Agree

2

3.
Neither
Agree or
Disagree
3

1

4

5

1

2

3

4

5

1

2

3

4

5

1
1

2
2

3
3

4
4

5
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

5
5
5
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Demographic Factors
Please circle the response that most closely corresponds to you. As with the survey, all
responses will be kept confidential
What is your gender?

Male
Female
What is your current age?
65 -70
70- 75
75 or greater
What Race/Ethnicity group do you consider European Americans
yourself?
African Americans
Hispanic
Asians
Other, specify:__________________.
What is your highest educational
Grade School
attainment?
Some High School
High School Diploma/GED
Some College
Bachelor Degree
Graduate/Professional Degree
What is your family’s annual income?
Under $10,000
$10,000 - $19,999
$20,000 - $29,999
$30,000 - $39,999
$40,000 - $49,999
$50,000 - $59,999
$60,000 or above.
Where do you reside?
Family house
Own house alone
Residence for senior citizens,
Other, specify: ………………………..
How many times did you have influenza
0 time
attack in the past one year?
1 time
2 times
3 times
4 or more times
How recently did you receive influenza
Never
vaccination?
More than three years,
2-3 years ago,
Last year
This year.
END. Thank you for completing the Influenza Vaccine Survey!
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Appendix F: Letter of Invitation for Volunteers for Test-Retest Survey

Dear Volunteers,
I am inviting 50 older adults who will volunteer to participate in a study survey which
will include test/retest sample to help the validity of this study. If you volunteered to
participate in the test-retest survey the same test will be administered two times.
The purpose of this study is to identify perceived belief about uptake about influenza
vaccine uptake. I feel this research is important to identify the belief that is responsible to
poor influenza vaccine uptake. If you know any other older adults that might be willing to
participate in the survey test-retest, please invite them so they might complete my survey.
I hope to finish my data collection by July 30, 2015. Once I have my final dissertation
approved I hope to disseminate my findings anyone who is interested. Please contact for
any questions or concerns at XXX@waldenu.edu.
Thank you, again, for your help!
Cheryl Hilliman RN MSN FNP WCCN
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Appendix G: Test/Retest Participant Reminder Emailing
Dear Fellow Participants,
This is a reminder to participate in the Retest for the research study as previously
discussed. I selected 50 older adults who volunteered to participate to complete the study
survey a second time and be included in the test/retest sample to help the validity of this
study. These participants practice autonomously and are members of the senior centers in
Brooklyn, New York. I would like to, again, assess older adults’ perceptions of influenza
disease and influenza vaccine uptake. The purpose of this study is to identify perceived
beliefs that may contribute to poor uptake of the influenza vaccine among older adults.
The survey should take less than 15 to 20 minutes to complete.
Again, any information you provide will be kept confidential because no
signatures is required. The researcher will not use your personal information for any
purposes outside of this research project. Also, the researcher will not include your name
or anything else that could identify you in the study reports. Data will be kept secure by a
password protected computer that only the researcher will have access. Data will be kept
for a period of at least 5 years, as required by the university.
If you are still interested, I will be at the senior center at 9 am Wednesday morning which
is within 5 days from todays’ date.
Please contact me at the information for any questions or concerns. If you have
any questions about participants’ rights, it can be directed to a Walden University
representative at IRB@waldenu.edu.
Thank you
Cheryl Hilliman, RN, MSN, FNP, WCCN
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Appendix H: Letter of Invitation Prospective Participants
Study Title: Correlates of Influenza Vaccination Uptake among Older Adults
Dear Prospective Participants
You are cordially invited to participate in a research among older adults. Your senior
citizen center is invited to participate in this study because you are between the ages of 65
or older which makes you eligible for the study. The information that is collected will be
analyzed and added to the future knowledge of how to Identify:
● Strategies for maintaining and sustaining change related to increasing influenza
vaccine uptake; and
● Future implications of using the Health Belief Model to assess the perception and
beliefs of the older adults’ population especially in Brooklyn, New York.
It is very important that you read the entire consent form before agreeing to participate in
the study. This study is being conducted by Cheryl Hilliman, RN, a current doctoral
candidate at Walden University.
Background Information: Seasonal influenza outbreak usually occurs in the United
States in late fall through early spring, causing severe illnesses and death, especially
among the elderly and children (CDC, 2012). Although influenza affects all ages, the
elderly is particularly vulnerable because they often have chronic illnesses which put
them at a greater risk for influenza complications, including pneumonia (Molinari, et al,
2007). U. S. Census Bureau 2011 reported influenza and pneumonia is the 7th leading
cause of death among the older adults and the annual rate of influenza-associated death
among ages 65 and older is 45,321 deaths per 100,000 persons. The results obtained from
this survey can be used to develop interventions that are specific to methods of
decreasing the prevalence of influenza and its complication among older adults. If you
agree to participate in this study please sign and return this letter of invitation to Cheryl
Hilliman, email cheryl.hilliman@waldenu.edu
I agree to participate in this study
Signature (first name and last name initials only): ___________ Date: _______________
Senior Citizen Center Location________________
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Appendix I: Flyer Advertising Influenza Vaccine Research Study
Research Study to Identify why the Influenza Vaccine Uptake Rates are decreasing
among the Older Adults in Brooklyn, New York
Seasonal influenza is a contagious airborne respiratory disease that spreads from person
to person during episodes of coughing or sneezing or through contact with frequently
handled infected surfaces (CDC, 2012-2013). The influenza disease is caused by a group
of influenza viruses, Type A, B, and C (CDC, 2012-2013). Although influenza affects all
ages, the older adults are particularly vulnerable because they often have chronic illnesses
which put them at a greater risk for influenza complications, including pneumonia
(Molinari, et al, 2007). Immunization against influenza viruses is considered one of the
most important health interventions to control seasonal influenza and to prevent
unnecessary hospitalizations and premature deaths among the older adults yet many older
adults do not obtain the influenza vaccine (CDC, 2012).
WHY THIS STUDY IS NEEDED
This study is carried out in Brooklyn New York because a survey done among Brooklyn
residents reported that influenza and pneumonia combined is the third leading cause of
death in Brooklyn (SUNY Downstate Medical Center, 2010).
How you can contribute to Decreasing Influenza Hospitalization and Death Rates
among Older Adults?
Take the chance today and participate in the survey to help me determining the
relationship between perception and belief among the elderly Brooklyn residents and
their low influenza vaccination uptake rate. The study is being conducted as part of a
Walden University dissertation fulfillment requirement by Cheryl Hilliman. With great
honor I am encouraging you to participate in this survey to help clinicians in developing
appropriate interventions specific to your older adult population who is vulnerable
influenza and its complication.

Please call Cheryl Hilliman at (347) 675-7353
Cheryl.hilliman@waldenu.edu

or Email me at
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Appendix J: GPCOG Screening Test Authorization
Instructions: For these questions, simply check the box that best represents your answer.
These questions are to determine if you meet the criteria to participate in the survey
study.
1. Are you a member of this senior citizen center?

•
•

Yes

•
•

Yes

•
•

Yes

•
•

Yes

No
2. Are you read and write English?

No
3. Can you can you independently make appropriate decisions.

No
4. Do you live in Brooklyn?

No
5. Are you willing to participate in a 4 to 5 minutes screening to evaluate your
current cognitive status?

•
•

Yes

No
If you have answered yes to all the questions and you are willing to take the
screening to test your cognitive ability, please put your initials of first and last
names on the area provided below.
First and Last Name Initials _____
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Appendix K: GPCOG Screening Test
Participant Initials: __________________________ Date: _____________
Items

Correct

Incorrect

1: Name and Address for Subsequent Recall Test
Read the following to the patient:
I am going to give you a name and address. After I have said it, I
want you to repeat it. You must remember this name and address
because I am going to ask you to tell it to me it again in a few
minutes: Mary Jones, 342 East 83rd Street, Brooklyn. (Allow a
maximum of 4 attempts).
2. Time/Orientation
What is the date? (exact only)
3. Clock Drawing – use blank page
Please mark in all the numbers to indicate the hours of a clock
4. Please mark in hands to show 10 minutes past twelve o’clock
(12:00)
5. Information
Can you tell me something that happened in the news recently?
(Recently = in the last week. If a general answer is given, e.g. "war",
"lot of rain", ask for details. Only specific answer scores)
Recall
What was the name and address I asked you to remember?
Top of Form
Mary
Jones
342
East 83rd Street
Brooklyn
To get a total score, add the number of items answered correctly
Total correct (score out of 9)
1.
If patient scores 9, no significant cognitive impairment and further testing not
necessary.
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2.
3.

If patient scores 5-8, more information required. Proceed with Step 2, informant
section.
If patient scores 0-4, cognitive impairment is indicated. Conduct standard
investigations.
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Informant Interview
Date: ____________ Informant’s name: ________________________
Informant’s relationship to patient, i.e. informant is the patient’s: ___________________
These six questions ask how the patient is compared to when s/he was well, say 5 – 10
years ago.
Compared to a few years ago: you will choose any of the following answers
Don’t know _______ Yes _______ No __________ N/A ________
1.
Does the patient have more trouble remembering things that have happened
recently than s/he used to?
Don’t know _______ Yes _______ No __________ N/A ________
2.
Does he or she have more trouble recalling conversations a few days later?
Don’t know _______ Yes _______ No __________ N/A ________
3.
When speaking, does the patient have more difficulty in finding the right word or
tend to use the wrong words more often?
Don’t know _______ Yes _______ No __________ N/A ________
4.
Is the patient less able to manage money and financial affairs (e.g. paying bills,
budgeting)?
Don’t know _______ Yes _______ No __________ N/A ________
5.
Is the patient less able to manage his or her medication independently?
Don’t know _______ Yes _______ No __________ N/A ________
6.
Does the patient need more assistance with transport (either private or public)?
Don’t know _______ Yes _______ No __________ N/A ________
(If the patient has difficulties due only to physical problems, e.g. bad leg, tick ‘no’)
To get a total score, add the number of items answered ‘no’, ‘don’t know’ or ‘N/A’)
Total score (out of 6)
If patient scores 0-3, cognitive impairment is indicated. Conduct standard investigations.

